<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.4.549">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">

<meta name="author" content="John Graves">
<meta name="author" content="Ashley Leech">
<meta name="author" content="Jinyi Zhu">
<meta name="author" content="Marie Martin">
<meta name="author" content="Shawn Garbett">
<meta name="dcterms.date" content="2024-03-21">
<meta name="keywords" content="Cost-Effectiveness Analysis, Microsimulation, Discrete Event Simulation, Markov Cohort Models">

<title>Modeling Disability-Adjusted Life Years for Policy and Decision Analysis</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
  margin-bottom: 0em;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script src="site_libs/quarto-contrib/glightbox/glightbox.min.js"></script>
<link href="site_libs/quarto-contrib/glightbox/glightbox.min.css" rel="stylesheet">
<link href="site_libs/quarto-contrib/glightbox/lightbox.css" rel="stylesheet">
<script async="" src="https://hypothes.is/embed.js"></script>
<script>
  window.document.addEventListener("DOMContentLoaded", function (_event) {
    document.body.classList.add('hypothesis-enabled');
  });
</script>
<link href="site_libs/tabwid-1.1.3/tabwid.css" rel="stylesheet">
<script src="site_libs/tabwid-1.1.3/tabwid.js"></script>

  <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

<script type="text/javascript">
const typesetMath = (el) => {
  if (window.MathJax) {
    // MathJax Typeset
    window.MathJax.typeset([el]);
  } else if (window.katex) {
    // KaTeX Render
    var mathElements = el.getElementsByClassName("math");
    var macros = [];
    for (var i = 0; i < mathElements.length; i++) {
      var texText = mathElements[i].firstChild;
      if (mathElements[i].tagName == "SPAN") {
        window.katex.render(texText.data, mathElements[i], {
          displayMode: mathElements[i].classList.contains('display'),
          throwOnError: false,
          macros: macros,
          fleqn: false
        });
      }
    }
  }
}
window.Quarto = {
  typesetMath
};
</script>

<meta name="citation_title" content="Modeling Disability-Adjusted Life Years for Policy and Decision Analysis">
<meta name="citation_abstract" content="This study outlines methods for direct incorporation of multidimensional health outcomes in common decision modeling frameworks, with a particular focus on disability-adjusted life years (DALYs) and its constituent parts---years of life lived with disability (YLDs) and years of life lost to premature mortality (YLLs). Recognizing the wide spectrum of experience and programming comfort level among practitioners, we offer three approaches (beginner, intermediate and advanced). Our beginner approach draws on the Markov trace, while the intermediate approach facilitates more efficient estimation for computationally-intensive exercises (e.g., microsimulation, probabilistic sensitivity analyses) by incorporating non-Markovian tracking elements into transition probability matrices. Finally, our advanced approach adapts methods from mathematical demography. This approach allows for direct calculation of expected values without the need for a Markov trace, and facilitates additional insights because it can also solve for higher-order moments in the health outcome distribution (e.g., variance, skewness). Drawing on an existing disease progression discrete time Markov cohort model, we demonstrate exact or near- numeric equivalence of DALY estimates and cost-effectiveness analysis results across our three methods, and show that other commonly used &amp;amp;quot;shortcuts&quot; for estimating DALYs will not, in general, yield accurate estimates of DALY levels nor ICERs in a modeled population.
">
<meta name="citation_keywords" content="Cost-Effectiveness Analysis,Microsimulation,Discrete Event Simulation,Markov Cohort Models">
<meta name="citation_author" content="John Graves">
<meta name="citation_author" content="Ashley Leech">
<meta name="citation_author" content="Jinyi Zhu">
<meta name="citation_author" content="Marie Martin">
<meta name="citation_author" content="Shawn Garbett">
<meta name="citation_publication_date" content="2024-03-21">
<meta name="citation_cover_date" content="2024-03-21">
<meta name="citation_year" content="2024">
<meta name="citation_online_date" content="2024-03-21">
<meta name="citation_language" content="en">
<meta name="citation_journal_title" content="Citation title">
<meta name="citation_reference" content="citation_title=Calculating disability-adjusted-life-years lost (DALYs) in discrete-time;,citation_author=Bruce A Larson;,citation_publication_date=2013;,citation_cover_date=2013;,citation_year=2013;,citation_issue=1;,citation_volume=11;,citation_journal_title=Cost effectiveness and resource allocation;,citation_publisher=BioMed Central;">
<meta name="citation_reference" content="citation_title=Calculating QALYs, comparing QALY and DALY calculations;,citation_author=Franco Sassi;,citation_publication_date=2006;,citation_cover_date=2006;,citation_year=2006;,citation_issue=5;,citation_volume=21;,citation_journal_title=Health policy and planning;,citation_publisher=Oxford University Press;">
<meta name="citation_reference" content="citation_title=The vec-permutation matrix, the vec operator and Kronecker products: a review;,citation_author=Harold V. Henderson;,citation_author=S. R. Searle;,citation_publication_date=1981-01;,citation_cover_date=1981-01;,citation_year=1981;,citation_fulltext_html_url=http://dx.doi.org/10.1080/03081088108817379;,citation_issue=4;,citation_doi=10.1080/03081088108817379;,citation_volume=9;,citation_language=en;,citation_journal_title=Linear and Multilinear Algebra;">
<meta name="citation_reference" content="citation_title=Healthy longevity from incidence-based models: More kinds of health than stars in the sky;,citation_author=Hal Caswell;,citation_author=Silke Daalen;,citation_publication_date=2021-07-29;,citation_cover_date=2021-07-29;,citation_year=2021;,citation_fulltext_html_url=http://dx.doi.org/10.4054/demres.2021.45.13;,citation_doi=10.4054/demres.2021.45.13;,citation_volume=45;,citation_language=en;,citation_journal_title=Demographic Research;">
<meta name="citation_reference" content="citation_title=Finite markov processes and their applications. wiley;,citation_author=M. Iosifescu;,citation_publication_date=1980;,citation_cover_date=1980;,citation_year=1980;,citation_journal_title=New York;">
<meta name="citation_reference" content="citation_title=Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation;,citation_author=John Graves;,citation_author=Shawn Garbett;,citation_author=Zilu Zhou;,citation_author=Jonathan S. Schildcrout;,citation_author=Josh Peterson;,citation_publication_date=2021-03-18;,citation_cover_date=2021-03-18;,citation_year=2021;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X21995805;,citation_issue=4;,citation_doi=10.1177/0272989x21995805;,citation_volume=41;,citation_language=en;,citation_journal_title=Medical Decision Making;">
<meta name="citation_reference" content="citation_title=Matrix methods in health demography: a new approach to the stochastic analysis of healthy longevity and DALYs;,citation_author=Hal Caswell;,citation_author=Virginia Zarulli;,citation_publication_date=2018-06-07;,citation_cover_date=2018-06-07;,citation_year=2018;,citation_fulltext_html_url=http://dx.doi.org/10.1186/s12963-018-0165-5;,citation_issue=1;,citation_doi=10.1186/s12963-018-0165-5;,citation_volume=16;,citation_language=en;,citation_journal_title=Population Health Metrics;">
<meta name="citation_reference" content="citation_title=Strategies for the development of volcanic hazard maps in monogenetic volcanic fields: The example of La Palma (Canary Islands);,citation_author=José Marrero;,citation_author=Alicia García;,citation_author=Manuel Berrocoso;,citation_author=Ángeles Llinares;,citation_author=Antonio Rodríguez-Losada;,citation_author=R. Ortiz;,citation_publication_date=2019-07;,citation_cover_date=2019-07;,citation_year=2019;,citation_doi=10.1186/s13617-019-0085-5;,citation_volume=8;,citation_journal_title=Journal of Applied Volcanology;">
<meta name="citation_reference" content="citation_title=Mortality by cause for eight regions of the world: Global Burden of Disease Study;,citation_author=Christopher JL Murray;,citation_author=Alan D Lopez;,citation_publication_date=1997-05;,citation_cover_date=1997-05;,citation_year=1997;,citation_fulltext_html_url=http://dx.doi.org/10.1016/S0140-6736(96)07493-4;,citation_issue=9061;,citation_doi=10.1016/s0140-6736(96)07493-4;,citation_volume=349;,citation_language=en;,citation_journal_title=The Lancet;">
<meta name="citation_reference" content="citation_title=Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?;,citation_author=Xue Feng;,citation_author=David D. Kim;,citation_author=Joshua T. Cohen;,citation_author=Peter J. Neumann;,citation_author=Daniel A. Ollendorf;,citation_publication_date=2020-04;,citation_cover_date=2020-04;,citation_year=2020;,citation_fulltext_html_url=http://dx.doi.org/10.1017/S0266462320000124;,citation_issue=2;,citation_doi=10.1017/s0266462320000124;,citation_volume=36;,citation_language=en;,citation_journal_title=International Journal of Technology Assessment in Health Care;">
<meta name="citation_reference" content="citation_title=The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought;,citation_author=Thomas Wilkinson;,citation_author=Mark J. Sculpher;,citation_author=Karl Claxton;,citation_author=Paul Revill;,citation_author=Andrew Briggs;,citation_author=John A. Cairns;,citation_author=Yot Teerawattananon;,citation_author=Elias Asfaw;,citation_author=Ruth Lopert;,citation_author=Anthony J. Culyer;,citation_author=Damian G. Walker;,citation_publication_date=2016-12;,citation_cover_date=2016-12;,citation_year=2016;,citation_fulltext_html_url=http://dx.doi.org/10.1016/j.jval.2016.04.015;,citation_issue=8;,citation_doi=10.1016/j.jval.2016.04.015;,citation_volume=19;,citation_language=en;,citation_journal_title=Value in Health;">
<meta name="citation_reference" content="citation_title=An introductory tutorial on cohort state-transition models in r using a cost-effectiveness analysis example;,citation_author=Fernando Alarid-Escudero;,citation_author=Eline Krijkamp;,citation_author=Eva A Enns;,citation_author=Alan Yang;,citation_author=MG Myriam Hunink;,citation_author=Petros Pechlivanoglou;,citation_author=Hawre Jalal;,citation_publication_date=2023;,citation_cover_date=2023;,citation_year=2023;,citation_issue=1;,citation_volume=43;,citation_journal_title=Medical Decision Making;,citation_publisher=SAGE Publications Sage CA: Los Angeles, CA;">
<meta name="citation_reference" content="citation_title=A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example;,citation_author=Fernando Alarid-Escudero;,citation_author=Eline Krijkamp;,citation_author=Eva A. Enns;,citation_author=Alan Yang;,citation_author=M. G. Myriam Hunink;,citation_author=Petros Pechlivanoglou;,citation_author=Hawre Jalal;,citation_publication_date=2022-09-16;,citation_cover_date=2022-09-16;,citation_year=2022;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X221121747;,citation_issue=1;,citation_doi=10.1177/0272989x221121747;,citation_volume=43;,citation_language=en;,citation_journal_title=Medical Decision Making;">
<meta name="citation_reference" content="citation_title=Healthy longevity from incidence-based models: More kinds of health than stars in the sky;,citation_author=Hal Caswell;,citation_author=Silke Daalen;,citation_publication_date=2021-07-29;,citation_cover_date=2021-07-29;,citation_year=2021;,citation_fulltext_html_url=http://dx.doi.org/10.4054/demres.2021.45.13;,citation_doi=10.4054/demres.2021.45.13;,citation_volume=45;,citation_language=en;,citation_journal_title=Demographic Research;">
<meta name="citation_reference" content="citation_title=Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation;,citation_author=John Graves;,citation_author=Shawn Garbett;,citation_author=Zilu Zhou;,citation_author=Jonathan S. Schildcrout;,citation_author=Josh Peterson;,citation_publication_date=2021-03-18;,citation_cover_date=2021-03-18;,citation_year=2021;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X21995805;,citation_issue=4;,citation_doi=10.1177/0272989x21995805;,citation_volume=41;,citation_language=en;,citation_journal_title=Medical Decision Making;">
<meta name="citation_reference" content="citation_title=Finite markov processes and their applications. wiley;,citation_author=M. Iosifescu;,citation_publication_date=1980;,citation_cover_date=1980;,citation_year=1980;,citation_journal_title=New York;">
<meta name="citation_reference" content="citation_title=Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE;,citation_author=Melanie Y. Bertram;,citation_author=Jeremy A. Lauer;,citation_author=Karin Stenberg;,citation_author=Tessa Tan Torres Edejer;,citation_publication_date=2021-01-20;,citation_cover_date=2021-01-20;,citation_year=2021;,citation_fulltext_html_url=http://dx.doi.org/10.34172/ijhpm.2020.244;,citation_doi=10.34172/ijhpm.2020.244;,citation_language=en;,citation_journal_title=International Journal of Health Policy and Management;">
<meta name="citation_reference" content="citation_title=Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE;,citation_author=Melanie Y. Bertram;,citation_author=Jeremy A. Lauer;,citation_author=Karin Stenberg;,citation_author=Tessa Tan Torres Edejer;,citation_publication_date=2021-01-20;,citation_cover_date=2021-01-20;,citation_year=2021;,citation_fulltext_html_url=http://dx.doi.org/10.34172/ijhpm.2020.244;,citation_doi=10.34172/ijhpm.2020.244;,citation_language=en;,citation_journal_title=International Journal of Health Policy and Management;">
<meta name="citation_reference" content="citation_title=Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis;,citation_author=Ja Fox-Rushby;,citation_author=K Hanson;,citation_publication_date=2001-09-01;,citation_cover_date=2001-09-01;,citation_year=2001;,citation_fulltext_html_url=http://dx.doi.org/10.1093/heapol/16.3.326;,citation_issue=3;,citation_doi=10.1093/heapol/16.3.326;,citation_volume=16;,citation_journal_title=Health Policy and Planning;">
<meta name="citation_reference" content="citation_title=WHO methods and data sources for global burden of disease estimates 2000–2019;,citation_author=Geneva WHO;,citation_publication_date=2013;,citation_cover_date=2013;,citation_year=2013;,citation_fulltext_html_url=https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf;,citation_journal_title=Geneva: Department of Health Statistics and Information Systems;">
<meta name="citation_reference" content="citation_title=Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the Global Burden of Disease Study 2019;,citation_author=Christopher J L Murray;,citation_author=Aleksandr Y Aravkin;,citation_author=Peng Zheng;,citation_author=Cristiana Abbafati;,citation_author=Kaja M Abbas;,citation_author=Mohsen Abbasi-Kangevari;,citation_author=Foad Abd-Allah;,citation_author=Ahmed Abdelalim;,citation_author=Mohammad Abdollahi;,citation_author=Ibrahim Abdollahpour;,citation_author=Kedir Hussein Abegaz;,citation_author=Hassan Abolhassani;,citation_author=Victor Aboyans;,citation_author=Lucas Guimarães Abreu;,citation_author=Michael R M Abrigo;,citation_author=Ahmed Abualhasan;,citation_author=Laith Jamal Abu-Raddad;,citation_author=Abdelrahman I Abushouk;,citation_author=Maryam Adabi;,citation_author=Victor Adekanmbi;,citation_author=Abiodun Moshood Adeoye;,citation_author=Olatunji O Adetokunboh;,citation_author=Davoud Adham;,citation_author=Shailesh M Advani;,citation_author=Gina Agarwal;,citation_author=Seyed Mohammad Kazem Aghamir;,citation_author=Anurag Agrawal;,citation_author=Tauseef Ahmad;,citation_author=Keivan Ahmadi;,citation_author=Mehdi Ahmadi;,citation_author=Hamid Ahmadieh;,citation_author=Muktar Beshir Ahmed;,citation_author=Temesgen Yihunie Akalu;,citation_author=Rufus Olusola Akinyemi;,citation_author=Tomi Akinyemiju;,citation_author=Blessing Akombi;,citation_author=Chisom Joyqueenet Akunna;,citation_author=Fares Alahdab;,citation_author=Ziyad Al-Aly;,citation_author=Khurshid Alam;,citation_author=Samiah Alam;,citation_author=Tahiya Alam;,citation_author=Fahad Mashhour Alanezi;,citation_author=Turki M Alanzi;,citation_author=Biresaw Alemu;,citation_author=Khalid F Alhabib;,citation_author=Muhammad Ali;,citation_author=Saqib Ali;,citation_author=Gianfranco Alicandro;,citation_author=Cyrus Alinia;,citation_author=Vahid Alipour;,citation_author=Hesam Alizade;,citation_author=Syed Mohamed Aljunid;,citation_author=François Alla;,citation_author=Peter Allebeck;,citation_author=Amir Almasi-Hashiani;,citation_author=Hesham M Al-Mekhlafi;,citation_author=Jordi Alonso;,citation_author=Khalid A Altirkawi;,citation_author=Mostafa Amini-Rarani;,citation_author=Fatemeh Amiri;,citation_author=Dickson A Amugsi;,citation_author=Robert Ancuceanu;,citation_author=Deanna Anderlini;,citation_author=Jason A Anderson;,citation_author=Catalina Liliana Andrei;,citation_author=Tudorel Andrei;,citation_author=Colin Angus;,citation_author=Mina Anjomshoa;,citation_author=Fereshteh Ansari;,citation_author=Alireza Ansari-Moghaddam;,citation_author=Ippazio Cosimo Antonazzo;,citation_author=Carl Abelardo T Antonio;,citation_author=Catherine M Antony;,citation_author=Ernoiz Antriyandarti;,citation_author=Davood Anvari;,citation_author=Razique Anwer;,citation_author=Seth Christopher Yaw Appiah;,citation_author=Jalal Arabloo;,citation_author=Morteza Arab-Zozani;,citation_author=Filippo Ariani;,citation_author=Bahram Armoon;,citation_author=Johan Ärnlöv;,citation_author=Afsaneh Arzani;,citation_author=Mehran Asadi-Aliabadi;,citation_author=Ali A Asadi-Pooya;,citation_author=Charlie Ashbaugh;,citation_author=Michael Assmus;,citation_author=Zahra Atafar;,citation_author=Desta Debalkie Atnafu;,citation_author=Maha Moh’d Wahbi Atout;,citation_author=Floriane Ausloos;,citation_author=Marcel Ausloos;,citation_author=Beatriz Paulina Ayala Quintanilla;,citation_author=Getinet Ayano;,citation_author=Martin Amogre Ayanore;,citation_author=Samad Azari;,citation_author=Ghasem Azarian;,citation_author=Zelalem Nigussie Azene;,citation_author=Alaa Badawi;,citation_author=Ashish D Badiye;,citation_author=Mohammad Amin Bahrami;,citation_author=Mohammad Hossein Bakhshaei;,citation_author=Ahad Bakhtiari;,citation_author=Shankar M Bakkannavar;,citation_author=Alberto Baldasseroni;,citation_author=Kylie Ball;,citation_author=Shoshana H Ballew;,citation_author=Daniela Balzi;,citation_author=Maciej Banach;,citation_author=Srikanta K Banerjee;,citation_author=Agegnehu Bante Bante;,citation_author=Adhanom Gebreegziabher Baraki;,citation_author=Suzanne Lyn Barker-Collo;,citation_author=Till Winfried Bärnighausen;,citation_author=Lope H Barrero;,citation_author=Celine M Barthelemy;,citation_author=Lingkan Barua;,citation_author=Sanjay Basu;,citation_author=Bernhard T Baune;,citation_author=Mohsen Bayati;,citation_author=Jacob S Becker;,citation_author=Neeraj Bedi;,citation_author=Ettore Beghi;,citation_author=Yannick Béjot;,citation_author=Michellr L Bell;,citation_author=Fiona B Bennitt;,citation_author=Isabela M Bensenor;,citation_author=Kidanemaryam Berhe;,citation_author=Adam E Berman;,citation_author=Akshaya Srikanth Bhagavathula;,citation_author=Reshmi Bhageerathy;,citation_author=Neeraj Bhala;,citation_author=Dinesh Bhandari;,citation_author=Krittika Bhattacharyya;,citation_author=Zulfiqar A Bhutta;,citation_author=Ali Bijani;,citation_author=Boris Bikbov;,citation_author=Muhammad Shahdaat Bin Sayeed;,citation_author=Antonio Biondi;,citation_author=Binyam Minuye Birihane;,citation_author=Catherine Bisignano;,citation_author=Raaj Kishore Biswas;,citation_author=Helen Bitew;,citation_author=Somayeh Bohlouli;,citation_author=Mehdi Bohluli;,citation_author=Alexandra S Boon-Dooley;,citation_author=Guilherme Borges;,citation_author=Antonio Maria Borzì;,citation_author=Shiva Borzouei;,citation_author=Cristina Bosetti;,citation_author=Soufiane Boufous;,citation_author=Dejana Braithwaite;,citation_author=Nicholas J K Breitborde;,citation_author=Susanne Breitner;,citation_author=Hermann Brenner;,citation_author=Paul Svitil Briant;,citation_author=Andrey Nikolaevich Briko;,citation_author=Nikolay Ivanovich Briko;,citation_author=Gabrielle B Britton;,citation_author=Dana Bryazka;,citation_author=Blair R Bumgarner;,citation_author=Katrin Burkart;,citation_author=Richard Thomas Burnett;,citation_author=Sharath Burugina Nagaraja;,citation_author=Zahid A Butt;,citation_author=Florentino Luciano Caetano dos Santos;,citation_author=Leah E Cahill;,citation_author=Luis LA Alberto Cámera;,citation_author=Ismael R Campos-Nonato;,citation_author=Rosario Cárdenas;,citation_author=Giulia Carreras;,citation_author=Juan J Carrero;,citation_author=Felix Carvalho;,citation_author=Joao Mauricio Castaldelli-Maia;,citation_author=Carlos A Castañeda-Orjuela;,citation_author=Giulio Castelpietra;,citation_author=Franz Castro;,citation_author=Kate Causey;,citation_author=Christopher R Cederroth;,citation_author=Kelly M Cercy;,citation_author=Ester Cerin;,citation_author=Joht Singh Chandan;,citation_author=Kai-Lan Chang;,citation_author=Fiona J Charlson;,citation_author=Vijay Kumar Chattu;,citation_author=Sarika Chaturvedi;,citation_author=Nicolas Cherbuin;,citation_author=Odgerel Chimed-Ochir;,citation_author=Daniel Youngwhan Cho;,citation_author=Jee-Young Jasmine Choi;,citation_author=Hanne Christensen;,citation_author=Dinh-Toi Chu;,citation_author=Michael T Chung;,citation_author=Sheng-Chia Chung;,citation_author=Flavia M Cicuttini;,citation_author=Liliana G Ciobanu;,citation_author=Massimo Cirillo;,citation_author=Thomas Khaled Dwayne Classen;,citation_author=Aaron J Cohen;,citation_author=Kelly Compton;,citation_author=Owen R Cooper;,citation_author=Vera Marisa Costa;,citation_author=Ewerton Cousin;,citation_author=Richard G Cowden;,citation_author=Di H Cross;,citation_author=Jessica A Cruz;,citation_author=Saad M A Dahlawi;,citation_author=Albertino Antonio Moura Damasceno;,citation_author=Giovanni Damiani;,citation_author=Lalit Dandona;,citation_author=Rakhi Dandona;,citation_author=William James Dangel;,citation_author=Anna-Karin Danielsson;,citation_author=Paul I Dargan;,citation_author=Aso Mohammad Darwesh;,citation_author=Ahmad Daryani;,citation_author=Jai K Das;,citation_author=Rajat Das Gupta;,citation_author=José Neves;,citation_author=Claudio Alberto Dávila-Cervantes;,citation_author=Dragos Virgil Davitoiu;,citation_author=Diego De Leo;,citation_author=Louisa Degenhardt;,citation_author=Marissa DeLang;,citation_author=Robert Paul Dellavalle;,citation_author=Feleke Mekonnen Demeke;,citation_author=Gebre Teklemariam Demoz;,citation_author=Desalegn Getnet Demsie;,citation_author=Edgar Denova-Gutiérrez;,citation_author=Nikolaos Dervenis;,citation_author=Govinda Prasad Dhungana;,citation_author=Mostafa Dianatinasab;,citation_author=Diana Dias da Silva;,citation_author=Daniel Diaz;,citation_author=Zahra Sadat Dibaji Forooshani;,citation_author=Shirin Djalalinia;,citation_author=Hoa Thi Do;,citation_author=Klara Dokova;,citation_author=Fariba Dorostkar;,citation_author=Leila Doshmangir;,citation_author=Tim Robert Driscoll;,citation_author=Bruce B Duncan;,citation_author=Andre Rodrigues Duraes;,citation_author=Arielle Wilder Eagan;,citation_author=David Edvardsson;,citation_author=Nevine El Nahas;,citation_author=Iman El Sayed;,citation_author=Maha El Tantawi;,citation_author=Iffat Elbarazi;,citation_author=Islam Y Elgendy;,citation_author=Shaimaa I El-Jaafary;,citation_author=Iqbal RF Elyazar;,citation_author=Sophia Emmons-Bell;,citation_author=Holly E Erskine;,citation_author=Sharareh Eskandarieh;,citation_author=Saman Esmaeilnejad;,citation_author=Alireza Esteghamati;,citation_author=Kara Estep;,citation_author=Arash Etemadi;,citation_author=Atkilt Esaiyas Etisso;,citation_author=Jessica Fanzo;,citation_author=Mohammad Farahmand;,citation_author=Mohammad Fareed;,citation_author=Roghiyeh Faridnia;,citation_author=Andrea Farioli;,citation_author=Andre Faro;,citation_author=Mithila Faruque;,citation_author=Farshad Farzadfar;,citation_author=Nazir Fattahi;,citation_author=Mehdi Fazlzadeh;,citation_author=Valery L Feigin;,citation_author=Rachel Feldman;,citation_author=Seyed-Mohammad Fereshtehnejad;,citation_author=Eduarda Fernandes;,citation_author=Giannina Ferrara;,citation_author=Alize J Ferrari;,citation_author=Manuela L Ferreira;,citation_author=Irina Filip;,citation_author=Florian Fischer;,citation_author=James L Fisher;,citation_author=Luisa Sorio Flor;,citation_author=Nataliya A Foigt;,citation_author=Morenike Oluwatoyin Folayan;,citation_author=Artem Alekseevich Fomenkov;,citation_author=Lisa M Force;,citation_author=Masoud Foroutan;,citation_author=Richard Charles Franklin;,citation_author=Marisa Freitas;,citation_author=Weijia Fu;,citation_author=Takeshi Fukumoto;,citation_author=João M Furtado;,citation_author=Mohamed M Gad;,citation_author=Emmanuela Gakidou;,citation_author=Silvano Gallus;,citation_author=Alberto L Garcia-Basteiro;,citation_author=William M Gardner;,citation_author=Biniyam Sahiledengle Geberemariyam;,citation_author=Assefa Ayalew Ayalew Ayalew Gebreslassie;,citation_author=Abraham Geremew;,citation_author=Anna Gershberg Hayoon;,citation_author=Peter W Gething;,citation_author=Maryam Ghadimi;,citation_author=Keyghobad Ghadiri;,citation_author=Fatemeh Ghaffarifar;,citation_author=Mansour Ghafourifard;,citation_author=Farhad Ghamari;,citation_author=Ahmad Ghashghaee;,citation_author=Hesam Ghiasvand;,citation_author=Nermin Ghith;,citation_author=Asadollah Gholamian;,citation_author=Rakesh Ghosh;,citation_author=Paramjit Singh Gill;,citation_author=Themba G G Ginindza;,citation_author=Giorgia Giussani;,citation_author=Elena V Gnedovskaya;,citation_author=Salime Goharinezhad;,citation_author=Sameer Vali Gopalani;,citation_author=Giuseppe Gorini;,citation_author=Houman Goudarzi;,citation_author=Alessandra C Goulart;,citation_author=Felix Greaves;,citation_author=Michal Grivna;,citation_author=Giuseppe Grosso;,citation_author=Mohammed Ibrahim Mohialdeen Gubari;,citation_author=Harish Chander Gugnani;,citation_author=Rafael Alves Guimarães;,citation_author=Rashid Abdi Guled;,citation_author=Gaorui Guo;,citation_author=Yuming Guo;,citation_author=Rajeev Gupta;,citation_author=Tarun Gupta;,citation_author=Beatrix Haddock;,citation_author=Nima Hafezi-Nejad;,citation_author=Abdul Hafiz;,citation_author=Arvin Haj-Mirzaian;,citation_author=Arya Haj-Mirzaian;,citation_author=Brian J Hall;,citation_author=Iman Halvaei;,citation_author=Randah R Hamadeh;,citation_author=Samer Hamidi;,citation_author=Melanie S Hammer;,citation_author=Graeme J Hankey;,citation_author=Hamidreza Haririan;,citation_author=Josep Maria Haro;,citation_author=Ahmed I Hasaballah;,citation_author=Md Mehedi Hasan;,citation_author=Edris Hasanpoor;,citation_author=Abdiwahab Hashi;,citation_author=Soheil Hassanipour;,citation_author=Hadi Hassankhani;,citation_author=Rasmus J Havmoeller;,citation_author=Simon I Hay;,citation_author=Khezar Hayat;,citation_author=Golnaz Heidari;,citation_author=Reza Heidari-Soureshjani;,citation_author=Hannah J Henrikson;,citation_author=Molly E Herbert;,citation_author=Claudiu Herteliu;,citation_author=Fatemeh Heydarpour;,citation_author=Thomas R Hird;,citation_author=Hans W Hoek;,citation_author=Ramesh Holla;,citation_author=Praveen Hoogar;,citation_author=H Dean Hosgood;,citation_author=Naznin Hossain;,citation_author=Mostafa Hosseini;,citation_author=Mehdi Hosseinzadeh;,citation_author=Mihaela Hostiuc;,citation_author=Sorin Hostiuc;,citation_author=Mowafa Househ;,citation_author=Mohamed Hsairi;,citation_author=Vivian Chia-rong Hsieh;,citation_author=Guoqing Hu;,citation_author=Kejia Hu;,citation_author=Tanvir M Huda;,citation_author=Ayesha Humayun;,citation_author=Chantal K Huynh;,citation_author=Bing-Fang Hwang;,citation_author=Vincent C Iannucci;,citation_author=Segun Emmanuel Ibitoye;,citation_author=Nayu Ikeda;,citation_author=Kevin S Ikuta;,citation_author=Olayinka Stephen Ilesanmi;,citation_author=Irena M Ilic;,citation_author=Milena D Ilic;,citation_author=Leeberk Raja Inbaraj;,citation_author=Helen Ippolito;,citation_author=Usman Iqbal;,citation_author=Seyed Sina Naghibi Irvani;,citation_author=Caleb Mackay Salpeter Irvine;,citation_author=M Mofizul Islam;,citation_author=Sheikh Mohammed Shariful Islam;,citation_author=Hiroyasu Iso;,citation_author=Rebecca Q Ivers;,citation_author=Chidozie C D Iwu;,citation_author=Chinwe Juliana Iwu;,citation_author=Ihoghosa Osamuyi Iyamu;,citation_author=Jalil Jaafari;,citation_author=Kathryn H Jacobsen;,citation_author=Hussain Jafari;,citation_author=Morteza Jafarinia;,citation_author=Mohammad Ali Jahani;,citation_author=Mihajlo Jakovljevic;,citation_author=Farzad Jalilian;,citation_author=Spencer L James;,citation_author=Hosna Janjani;,citation_author=Tahereh Javaheri;,citation_author=Javad Javidnia;,citation_author=Panniyammakal Jeemon;,citation_author=Ensiyeh Jenabi;,citation_author=Ravi Prakash Jha;,citation_author=Vivekanand Jha;,citation_author=John S Ji;,citation_author=Lars Johansson;,citation_author=Oommen John;,citation_author=Yetunde O John-Akinola;,citation_author=Catherine Owens Johnson;,citation_author=Jost B Jonas;,citation_author=Farahnaz Joukar;,citation_author=Jacek Jerzy Jozwiak;,citation_author=Mikk Jürisson;,citation_author=Ali Kabir;,citation_author=Zubair Kabir;,citation_author=Hamed Kalani;,citation_author=Rizwan Kalani;,citation_author=Leila R Kalankesh;,citation_author=Rohollah Kalhor;,citation_author=Tanuj Kanchan;,citation_author=Neeti Kapoor;,citation_author=Behzad Karami Matin;,citation_author=André Karch;,citation_author=Mohd Anisul Karim;,citation_author=Getachew Mullu Kassa;,citation_author=Srinivasa Vittal Katikireddi;,citation_author=Gbenga A Kayode;,citation_author=Ali Kazemi Karyani;,citation_author=Peter Njenga Keiyoro;,citation_author=Cathleen Keller;,citation_author=Laura Kemmer;,citation_author=Parkes J Kendrick;,citation_author=Nauman Khalid;,citation_author=Mohammad Khammarnia;,citation_author=Ejaz Ahmad Khan;,citation_author=Maseer Khan;,citation_author=Khaled Khatab;,citation_author=Mona M Khater;,citation_author=Mahalaqua Nazli Khatib;,citation_author=Maryam Khayamzadeh;,citation_author=Salman Khazaei;,citation_author=Christian Kieling;,citation_author=Yun Jin Kim;,citation_author=Ruth W Kimokoti;,citation_author=Adnan Kisa;,citation_author=Sezer Kisa;,citation_author=Mika Kivimäki;,citation_author=Luke D Knibbs;,citation_author=Ann Kristin Skrindo Knudsen;,citation_author=Jonathan M Kocarnik;,citation_author=Sonali Kochhar;,citation_author=Jacek A Kopec;,citation_author=Vladimir Andreevich Korshunov;,citation_author=Parvaiz A Koul;,citation_author=Ai Koyanagi;,citation_author=Moritz U G Kraemer;,citation_author=Kewal Krishan;,citation_author=Kris J Krohn;,citation_author=Hans Kromhout;,citation_author=Barthelemy Kuate Defo;,citation_author=G Anil Kumar;,citation_author=Vivek Kumar;,citation_author=Om P Kurmi;,citation_author=Dian Kusuma;,citation_author=Carlo La Vecchia;,citation_author=Ben Lacey;,citation_author=Dharmesh Kumar Lal;,citation_author=Ratilal Lalloo;,citation_author=Tea Lallukka;,citation_author=Faris Hasan Lami;,citation_author=Iván Landires;,citation_author=Justin J Lang;,citation_author=Sinéad M Langan;,citation_author=Anders O Larsson;,citation_author=Savita Lasrado;,citation_author=Paolo Lauriola;,citation_author=Jeffrey V Lazarus;,citation_author=Paul H Lee;,citation_author=Shaun Wen Huey Lee;,citation_author=Kate E LeGrand;,citation_author=James Leigh;,citation_author=Matilde Leonardi;,citation_author=Haley Lescinsky;,citation_author=Janni Leung;,citation_author=Miriam Levi;,citation_author=Shanshan Li;,citation_author=Lee-Ling Lim;,citation_author=Shai Linn;,citation_author=Shiwei Liu;,citation_author=Simin Liu;,citation_author=Yang Liu;,citation_author=Justin Lo;,citation_author=Alan D Lopez;,citation_author=Jaifred Christian F Lopez;,citation_author=Platon D Lopukhov;,citation_author=Stefan Lorkowski;,citation_author=Paulo A Lotufo;,citation_author=Alton Lu;,citation_author=Alessandra Lugo;,citation_author=Emilie R Maddison;,citation_author=Phetole Walter Mahasha;,citation_author=Mokhtar Mahdavi Mahdavi;,citation_author=Morteza Mahmoudi;,citation_author=Azeem Majeed;,citation_author=Afshin Maleki;,citation_author=Shokofeh Maleki;,citation_author=Reza Malekzadeh;,citation_author=Deborah Carvalho Malta;,citation_author=Abdullah A Mamun;,citation_author=Ana Laura Manda;,citation_author=Helena Manguerra;,citation_author=Fariborz Mansour-Ghanaei;,citation_author=Borhan Mansouri;,citation_author=Mohammad Ali Mansournia;,citation_author=Ana M Mantilla Herrera;,citation_author=Joemer C Maravilla;,citation_author=Ashley Marks;,citation_author=Randall V Martin;,citation_author=Santi Martini;,citation_author=Francisco Rogerlândio Martins-Melo;,citation_author=Anthony Masaka;,citation_author=Seyedeh Zahra Masoumi;,citation_author=Manu Raj Mathur;,citation_author=Kunihiro Matsushita;,citation_author=Pallab K Maulik;,citation_author=Colm McAlinden;,citation_author=John J McGrath;,citation_author=Martin McKee;,citation_author=Man Mohan Mehndiratta;,citation_author=Fereshteh Mehri;,citation_author=Kala M Mehta;,citation_author=Ziad A Memish;,citation_author=Walter Mendoza;,citation_author=Ritesh G Menezes;,citation_author=Endalkachew Worku Mengesha;,citation_author=Alibek Mereke;,citation_author=Seid Tiku Mereta;,citation_author=Atte Meretoja;,citation_author=Tuomo J Meretoja;,citation_author=Tomislav Mestrovic;,citation_author=Bartosz Miazgowski;,citation_author=Tomasz Miazgowski;,citation_author=Irmina Maria Michalek;,citation_author=Ted R Miller;,citation_author=Edward J Mills;,citation_author=GK Mini;,citation_author=Mohammad Miri;,citation_author=Andreea Mirica;,citation_author=Erkin M Mirrakhimov;,citation_author=Hamed Mirzaei;,citation_author=Maryam Mirzaei;,citation_author=Roya Mirzaei;,citation_author=Mehdi Mirzaei-Alavijeh;,citation_author=Awoke Temesgen Misganaw;,citation_author=Prasanna Mithra;,citation_author=Babak Moazen;,citation_author=Dara K Mohammad;,citation_author=Yousef Mohammad;,citation_author=Naser Mohammad Gholi Mezerji;,citation_author=Abdollah Mohammadian-Hafshejani;,citation_author=Noushin Mohammadifard;,citation_author=Reza Mohammadpourhodki;,citation_author=Ammas Siraj Mohammed;,citation_author=Hussen Mohammed;,citation_author=Jemal Abdu Mohammed;,citation_author=Shafiu Mohammed;,citation_author=Ali H Mokdad;,citation_author=Mariam Molokhia;,citation_author=Lorenzo Monasta;,citation_author=Meghan D Mooney;,citation_author=Ghobad Moradi;,citation_author=Masoud Moradi;,citation_author=Maziar Moradi-Lakeh;,citation_author=Rahmatollah Moradzadeh;,citation_author=Paula Moraga;,citation_author=Lidia Morawska;,citation_author=Joana Morgado-da-Costa;,citation_author=Shane Douglas Morrison;,citation_author=Abbas Mosapour;,citation_author=Jonathan F Mosser;,citation_author=Simin Mouodi;,citation_author=Seyyed Meysam Mousavi;,citation_author=Amin Mousavi Khaneghah;,citation_author=Ulrich Otto Mueller;,citation_author=Satinath Mukhopadhyay;,citation_author=Erin C Mullany;,citation_author=Kamarul Imran Musa;,citation_author=Saravanan Muthupandian;,citation_author=Ashraf F Nabhan;,citation_author=Mehdi Naderi;,citation_author=Ahamarshan Jayaraman Nagarajan;,citation_author=Gabriele Nagel;,citation_author=Mohsen Naghavi;,citation_author=Behshad Naghshtabrizi;,citation_author=Mukhammad David Naimzada;,citation_author=Farid Najafi;,citation_author=Vinay Nangia;,citation_author=Jobert Richie Nansseu;,citation_author=Morteza Naserbakht;,citation_author=Vinod C Nayak;,citation_author=Ionut Negoi;,citation_author=Josephine W Ngunjiri;,citation_author=Cuong Tat Nguyen;,citation_author=Huong Lan Thi Nguyen;,citation_author=Minh Nguyen;,citation_author=Yeshambel T Nigatu;,citation_author=Rajan Nikbakhsh;,citation_author=Molly R Nixon;,citation_author=Chukwudi A Nnaji;,citation_author=Shuhei Nomura;,citation_author=Bo Norrving;,citation_author=Jean Jacques Noubiap;,citation_author=Christoph Nowak;,citation_author=Virginia Nunez-Samudio;,citation_author=Adrian Oţoiu;,citation_author=Bogdan Oancea;,citation_author=Christopher M Odell;,citation_author=Felix Akpojene Ogbo;,citation_author=In-Hwan Oh;,citation_author=Emmanuel Wandera Okunga;,citation_author=Morteza Oladnabi;,citation_author=Andrew T Olagunju;,citation_author=Bolajoko Olubukunola Olusanya;,citation_author=Jacob Olusegun Olusanya;,citation_author=Muktar Omer Omer;,citation_author=Kanyin L Ong;,citation_author=Obinna E Onwujekwe;,citation_author=Heather M Orpana;,citation_author=Alberto Ortiz;,citation_author=Osayomwanbo Osarenotor;,citation_author=Frank B Osei;,citation_author=Samuel M Ostroff;,citation_author=Nikita Otstavnov;,citation_author=Stanislav S Otstavnov;,citation_author=Simon Øverland;,citation_author=Mayowa O Owolabi;,citation_author=Mahesh P A;,citation_author=Jagadish Rao Padubidri;,citation_author=Raffaele Palladino;,citation_author=Songhomitra Panda-Jonas;,citation_author=Anamika Pandey;,citation_author=Charles D H Parry;,citation_author=Maja Pasovic;,citation_author=Deepak Kumar Pasupula;,citation_author=Sangram Kishor Patel;,citation_author=Mona Pathak;,citation_author=Scott B Patten;,citation_author=George C Patton;,citation_author=Hamidreza Pazoki Toroudi;,citation_author=Amy E Peden;,citation_author=Alyssa Pennini;,citation_author=Veincent Christian Filipino Pepito;,citation_author=Emmanuel K Peprah;,citation_author=David M Pereira;,citation_author=Konrad Pesudovs;,citation_author=Hai Quang Pham;,citation_author=Michael R Phillips;,citation_author=Cristiano Piccinelli;,citation_author=Tessa M Pilz;,citation_author=Michael A Piradov;,citation_author=Meghdad Pirsaheb;,citation_author=Dietrich Plass;,citation_author=Suzanne Polinder;,citation_author=Kevan R Polkinghorne;,citation_author=Constance Dimity Pond;,citation_author=Maarten J Postma;,citation_author=Hadi Pourjafar;,citation_author=Farshad Pourmalek;,citation_author=Anna Poznańska;,citation_author=Sergio I Prada;,citation_author=V Prakash;,citation_author=Dimas Ria Angga Pribadi;,citation_author=Elisabetta Pupillo;,citation_author=Zahiruddin Quazi Syed;,citation_author=Mohammad Rabiee;,citation_author=Navid Rabiee;,citation_author=Amir Radfar;,citation_author=Ata Rafiee;,citation_author=Alberto Raggi;,citation_author=Muhammad Aziz Rahman;,citation_author=Ali Rajabpour-Sanati;,citation_author=Fatemeh Rajati;,citation_author=Ivo Rakovac;,citation_author=Pradhum Ram;,citation_author=Kiana Ramezanzadeh;,citation_author=Chhabi Lal Ranabhat;,citation_author=Puja C Rao;,citation_author=Sowmya J Rao;,citation_author=Vahid Rashedi;,citation_author=Priya Rathi;,citation_author=David Laith Rawaf;,citation_author=Salman Rawaf;,citation_author=Lal Rawal;,citation_author=Reza Rawassizadeh;,citation_author=Ramu Rawat;,citation_author=Christian Razo;,citation_author=Sofia Boston Redford;,citation_author=Robert C Reiner;,citation_author=Marissa Bettay Reitsma;,citation_author=Giuseppe Remuzzi;,citation_author=Vishnu Renjith;,citation_author=Andre M N Renzaho;,citation_author=Serge Resnikoff;,citation_author=Negar Rezaei;,citation_author=Nima Rezaei;,citation_author=Aziz Rezapour;,citation_author=Phoebe-Anne Rhinehart;,citation_author=Seyed Mohammad Riahi;,citation_author=Daniel Cury Ribeiro;,citation_author=Daniela Ribeiro;,citation_author=Jennifer Rickard;,citation_author=Juan A Rivera;,citation_author=Nicholas L S Roberts;,citation_author=Sonia Rodríguez-Ramírez;,citation_author=Leonardo Roever;,citation_author=Luca Ronfani;,citation_author=Robin Room;,citation_author=Gholamreza Roshandel;,citation_author=Gregory A Roth;,citation_author=Dietrich Rothenbacher;,citation_author=Enrico Rubagotti;,citation_author=Godfrey M Rwegerera;,citation_author=Siamak Sabour;,citation_author=Perminder S Sachdev;,citation_author=Basema Saddik;,citation_author=Ehsan Sadeghi;,citation_author=Masoumeh Sadeghi;,citation_author=Reza Saeedi;,citation_author=Sahar Saeedi Moghaddam;,citation_author=Yahya Safari;,citation_author=Sare Safi;,citation_author=Saeid Safiri;,citation_author=Rajesh Sagar;,citation_author=Amirhossein Sahebkar;,citation_author=S Mohammad Sajadi;,citation_author=Nasir Salam;,citation_author=Payman Salamati;,citation_author=Hosni Salem;,citation_author=Marwa R Rashad Salem;,citation_author=Hamideh Salimzadeh;,citation_author=Omar Mukhtar Salman;,citation_author=Joshua A Salomon;,citation_author=Zainab Samad;,citation_author=Hossein Samadi Kafil;,citation_author=Evanson Zondani Sambala;,citation_author=Abdallah M Samy;,citation_author=Juan Sanabria;,citation_author=Tania G Sánchez-Pimienta;,citation_author=Damian Francesco Santomauro;,citation_author=Itamar S Santos;,citation_author=João Vasco Santos;,citation_author=Milena M Santric-Milicevic;,citation_author=Sivan Yegnanarayana Iyer Saraswathy;,citation_author=Rodrigo Sarmiento-Suárez;,citation_author=Nizal Sarrafzadegan;,citation_author=Benn Sartorius;,citation_author=Arash Sarveazad;,citation_author=Brijesh Sathian;,citation_author=Thirunavukkarasu Sathish;,citation_author=Davide Sattin;,citation_author=Sonia Saxena;,citation_author=Lauren E Schaeffer;,citation_author=Silvia Schiavolin;,citation_author=Markus P Schlaich;,citation_author=Maria Inês Schmidt;,citation_author=Aletta Elisabeth Schutte;,citation_author=David C Schwebel;,citation_author=Falk Schwendicke;,citation_author=Anbissa Muleta Senbeta;,citation_author=Subramanian Senthilkumaran;,citation_author=Sadaf G Sepanlou;,citation_author=Berrin Serdar;,citation_author=Marc L Serre;,citation_author=Jamileh Shadid;,citation_author=Omid Shafaat;,citation_author=Saeed Shahabi;,citation_author=Amira A Shaheen;,citation_author=Masood Ali Shaikh;,citation_author=Ali S Shalash;,citation_author=Mehran Shams-Beyranvand;,citation_author=Morteza Shamsizadeh;,citation_author=Kiomars Sharafi;,citation_author=Aziz Sheikh;,citation_author=Abbas Sheikhtaheri;,citation_author=Kenji Shibuya;,citation_author=Kevin David Shield;,citation_author=Mika Shigematsu;,citation_author=Jae Il Shin;,citation_author=Min-Jeong Shin;,citation_author=Rahman Shiri;,citation_author=Reza Shirkoohi;,citation_author=Kerem Shuval;,citation_author=Soraya Siabani;,citation_author=Radoslaw Sierpinski;,citation_author=Inga Dora Sigfusdottir;,citation_author=Rannveig Sigurvinsdottir;,citation_author=João Pedro Silva;,citation_author=Kyle E Simpson;,citation_author=Jasvinder A Singh;,citation_author=Pushpendra Singh;,citation_author=Eirini Skiadaresi;,citation_author=Søren T Skou;,citation_author=Valentin Yurievich Skryabin;,citation_author=Emma U R Smith;,citation_author=Amin Soheili;,citation_author=Shahin Soltani;,citation_author=Moslem Soofi;,citation_author=Reed J D Sorensen;,citation_author=Joan B Soriano;,citation_author=Muluken Bekele Sorrie;,citation_author=Sergey Soshnikov;,citation_author=Ireneous N Soyiri;,citation_author=Cory N Spencer;,citation_author=Adel Spotin;,citation_author=Chandrashekhar T Sreeramareddy;,citation_author=Vinay Srinivasan;,citation_author=Jeffrey D Stanaway;,citation_author=Caroline Stein;,citation_author=Dan J Stein;,citation_author=Caitlyn Steiner;,citation_author=Leo Stockfelt;,citation_author=Mark A Stokes;,citation_author=Kurt Straif;,citation_author=Jacob L Stubbs;,citation_author=Mu’awiyyah Babale Sufiyan;,citation_author=Hafiz Ansar Rasul Suleria;,citation_author=Rizwan Suliankatchi Abdulkader;,citation_author=Gerhard Sulo;,citation_author=Iyad Sultan;,citation_author=Łukasz Szumowski;,citation_author=Rafael Tabarés-Seisdedos;,citation_author=Karen M Tabb;,citation_author=Takahiro Tabuchi;,citation_author=Amir Taherkhani;,citation_author=Masih Tajdini;,citation_author=Ken Takahashi;,citation_author=Jukka S Takala;,citation_author=Animut Tagele Tamiru;,citation_author=Nuno Taveira;,citation_author=Arash Tehrani-Banihashemi;,citation_author=Mohamad-Hani Temsah;,citation_author=Getayeneh Antehunegn Tesema;,citation_author=Zemenu Tadesse Tessema;,citation_author=George D Thurston;,citation_author=Mariya Vladimirovna Titova;,citation_author=Hamid Reza Tohidinik;,citation_author=Marcello Tonelli;,citation_author=Roman Topor-Madry;,citation_author=Fotis Topouzis;,citation_author=Anna E Torre;,citation_author=Mathilde Touvier;,citation_author=Marcos Roberto Roberto Tovani-Palone;,citation_author=Bach Xuan Tran;,citation_author=Ravensara Travillian;,citation_author=Aristidis Tsatsakis;,citation_author=Lorainne Tudor Car;,citation_author=Stefanos Tyrovolas;,citation_author=Riaz Uddin;,citation_author=Chukwuma David Umeokonkwo;,citation_author=Bhaskaran Unnikrishnan;,citation_author=Era Upadhyay;,citation_author=Marco Vacante;,citation_author=Pascual R Valdez;,citation_author=Aaron Donkelaar;,citation_author=Tommi Juhani Vasankari;,citation_author=Yasser Vasseghian;,citation_author=Yousef Veisani;,citation_author=Narayanaswamy Venketasubramanian;,citation_author=Francesco S Violante;,citation_author=Vasily Vlassov;,citation_author=Stein Emil Vollset;,citation_author=Theo Vos;,citation_author=Rade Vukovic;,citation_author=Yasir Waheed;,citation_author=Mitchell Taylor Wallin;,citation_author=Yafeng Wang;,citation_author=Yuan-Pang Wang;,citation_author=Alexandrea Watson;,citation_author=Jingkai Wei;,citation_author=Melissa Y Wei Wei;,citation_author=Robert G Weintraub;,citation_author=Jordan Weiss;,citation_author=Andrea Werdecker;,citation_author=J Jason West;,citation_author=Ronny Westerman;,citation_author=Joanna L Whisnant;,citation_author=Harvey A Whiteford;,citation_author=Kirsten E Wiens;,citation_author=Charles D A Wolfe;,citation_author=Sarah S Wozniak;,citation_author=Ai-Min Wu;,citation_author=Junjie Wu;,citation_author=Sarah Wulf Hanson;,citation_author=Gelin Xu;,citation_author=Rixing Xu;,citation_author=Simon Yadgir;,citation_author=Seyed Hossein Yahyazadeh Jabbari;,citation_author=Kazumasa Yamagishi;,citation_author=Mousa Yaminfirooz;,citation_author=Yuichiro Yano;,citation_author=Sanni Yaya;,citation_author=Vahid Yazdi-Feyzabadi;,citation_author=Tomas Y Yeheyis;,citation_author=Christopher Sabo Yilgwan;,citation_author=Mekdes Tigistu Yilma;,citation_author=Paul Yip;,citation_author=Naohiro Yonemoto;,citation_author=Mustafa Z Younis;,citation_author=Theodore Patrick Younker;,citation_author=Bahman Yousefi;,citation_author=Zabihollah Yousefi;,citation_author=Taraneh Yousefinezhadi;,citation_author=Abdilahi Yousuf Yousuf;,citation_author=Chuanhua Yu;,citation_author=Hasan Yusefzadeh;,citation_author=Telma Zahirian Moghadam;,citation_author=Mohammad Zamani;,citation_author=Maryam Zamanian;,citation_author=Hamed Zandian;,citation_author=Mikhail Sergeevich Zastrozhin;,citation_author=Yunquan Zhang;,citation_author=Zhi-Jiang Zhang;,citation_author=Jeff T Zhao;,citation_author=Xiu-Ju George Zhao;,citation_author=Yingxi Zhao;,citation_author=Maigeng Zhou;,citation_author=Arash Ziapour;,citation_author=Stephanie R M Zimsen;,citation_author=Michael Brauer;,citation_author=Ashkan Afshin;,citation_author=Stephen S Lim;,citation_publication_date=2020-10;,citation_cover_date=2020-10;,citation_year=2020;,citation_fulltext_html_url=http://dx.doi.org/10.1016/S0140-6736(20)30752-2;,citation_issue=10258;,citation_doi=10.1016/s0140-6736(20)30752-2;,citation_volume=396;,citation_language=en;,citation_journal_title=The Lancet;">
<meta name="citation_reference" content="citation_title=Global burden of disease study 2019 (GBD 2019) reference life table;,citation_author=Global Burden of Disease Collaborative Network;,citation_publication_date=2021;,citation_cover_date=2021;,citation_year=2021;,citation_fulltext_html_url=http://ghdx.healthdata.org/record/ihme-data/global-burden-disease-study-2019-gbd-2019-reference-life-table;,citation_doi=10.6069/1D4Y-YQ37;,citation_publisher=Institute for Health Metrics; Evaluation (IHME);">
<meta name="citation_reference" content="citation_title=Improving cycle corrections in discrete time markov models: A gaussian quadrature approach;,citation_author=Tushar Srivastava;,citation_author=Mark Strong;,citation_author=Matthew D Stevenson;,citation_author=Peter J Dodd;,citation_publication_date=2020-07-29;,citation_cover_date=2020-07-29;,citation_year=2020;,citation_fulltext_html_url=http://dx.doi.org/10.1101/2020.07.27.20162651;">
<meta name="citation_reference" content="citation_title=The Construction of the DALY: Implications and Anomalies;,citation_author=Sudhir Anand;,citation_author=Sanjay G. Reddy;,citation_publication_date=2019;,citation_cover_date=2019;,citation_year=2019;,citation_fulltext_html_url=http://dx.doi.org/10.2139/ssrn.3451311;,citation_doi=10.2139/ssrn.3451311;,citation_language=en;,citation_journal_title=SSRN Electronic Journal;">
<meta name="citation_reference" content="citation_title=Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness;,citation_author=Beate Jahn;,citation_author=Christina Kurzthaler;,citation_author=Jagpreet Chhatwal;,citation_author=Elamin H. Elbasha;,citation_author=Annette Conrads-Frank;,citation_author=Ursula Rochau;,citation_author=Gaby Sroczynski;,citation_author=Christoph Urach;,citation_author=Marvin Bundo;,citation_author=Niki Popper;,citation_author=Uwe Siebert;,citation_publication_date=2019-06-28;,citation_cover_date=2019-06-28;,citation_year=2019;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X19851095;,citation_issue=5;,citation_doi=10.1177/0272989x19851095;,citation_volume=39;,citation_language=en;,citation_journal_title=Medical Decision Making;">
<meta name="citation_reference" content="citation_title=Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial;,citation_author=Eline M. Krijkamp;,citation_author=Fernando Alarid-Escudero;,citation_author=Eva A. Enns;,citation_author=Hawre J. Jalal;,citation_author=M. G. Myriam Hunink;,citation_author=Petros Pechlivanoglou;,citation_publication_date=2018-03-27;,citation_cover_date=2018-03-27;,citation_year=2018;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X18754513;,citation_issue=3;,citation_doi=10.1177/0272989x18754513;,citation_volume=38;,citation_language=en;,citation_journal_title=Medical Decision Making;">
<meta name="citation_reference" content="citation_title=Modeling Using Discrete Event Simulation;,citation_author=Jonathan Karnon;,citation_author=James Stahl;,citation_author=Alan Brennan;,citation_author=J. Jaime Caro;,citation_author=Javier Mar;,citation_author=Jörgen Möller;,citation_publication_date=2012-09;,citation_cover_date=2012-09;,citation_year=2012;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X12455462;,citation_issue=5;,citation_doi=10.1177/0272989x12455462;,citation_volume=32;,citation_language=en;,citation_journal_title=Medical Decision Making;">
<meta name="citation_reference" content="citation_title=Advantages and disadvantages of discrete-event simulation for health economic analyses;,citation_author=J. Jaime Caro;,citation_author=Jörgen Möller;,citation_publication_date=2016-03-25;,citation_cover_date=2016-03-25;,citation_year=2016;,citation_fulltext_html_url=http://dx.doi.org/10.1586/14737167.2016.1165608;,citation_issue=3;,citation_doi=10.1586/14737167.2016.1165608;,citation_volume=16;,citation_language=en;,citation_journal_title=Expert Review of Pharmacoeconomics &amp;amp;amp; Outcomes Research;">
<meta name="citation_reference" content="citation_title=Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial;,citation_author=Eline M. Krijkamp;,citation_author=Fernando Alarid-Escudero;,citation_author=Eva A. Enns;,citation_author=Hawre J. Jalal;,citation_author=M. G. Myriam Hunink;,citation_author=Petros Pechlivanoglou;,citation_publication_date=2018-03-27;,citation_cover_date=2018-03-27;,citation_year=2018;,citation_fulltext_html_url=http://dx.doi.org/10.1177/0272989X18754513;,citation_issue=3;,citation_doi=10.1177/0272989x18754513;,citation_volume=38;,citation_language=en;,citation_journal_title=Medical Decision Making;">
</head>

<body>

<header id="title-block-header" class="quarto-title-block default toc-left page-columns page-full">
  <div class="quarto-title-banner page-columns page-full">
    <div class="quarto-title column-body">
      <h1 class="title">Modeling Disability-Adjusted Life Years for Policy and Decision Analysis</h1>
          </div>

    
    <div class="quarto-title-meta-container">
      <div class="quarto-title-meta-column-start">
        
        <div class="quarto-title-meta">

                <div>
            <div class="quarto-title-meta-heading">Authors</div>
            <div class="quarto-title-meta-contents">
                        <p>John Graves </p>
                        <p>Ashley Leech </p>
                        <p>Jinyi Zhu </p>
                        <p>Marie Martin </p>
                        <p>Shawn Garbett </p>
                      </div>
          </div>
                
                <div>
            <div class="quarto-title-meta-heading">Published</div>
            <div class="quarto-title-meta-contents">
              <p class="date">March 21, 2024</p>
            </div>
          </div>
          
                
              </div>
      </div>
      <div class="quarto-title-meta-column-end quarto-other-formats-target">
      <div class="quarto-alternate-formats"><div class="quarto-title-meta-heading">Other Formats</div><div class="quarto-title-meta-contents"><p><a href="index.docx"><i class="bi bi-file-word"></i>MS Word</a></p></div></div></div>
    </div>

    <div>
      <div class="abstract">
        <div class="block-title">Abstract</div>
        <p>This study outlines methods for direct incorporation of multidimensional health outcomes in common decision modeling frameworks, with a particular focus on disability-adjusted life years (DALYs) and its constituent parts—years of life lived with disability (YLDs) and years of life lost to premature mortality (YLLs). Recognizing the wide spectrum of experience and programming comfort level among practitioners, we offer three approaches (beginner, intermediate and advanced). Our beginner approach draws on the Markov trace, while the intermediate approach facilitates more efficient estimation for computationally-intensive exercises (e.g., microsimulation, probabilistic sensitivity analyses) by incorporating non-Markovian tracking elements into transition probability matrices. Finally, our advanced approach adapts methods from mathematical demography. This approach allows for direct calculation of expected values without the need for a Markov trace, and facilitates additional insights because it can also solve for higher-order moments in the health outcome distribution (e.g., variance, skewness). Drawing on an existing disease progression discrete time Markov cohort model, we demonstrate exact or near- numeric equivalence of DALY estimates and cost-effectiveness analysis results across our three methods, and show that other commonly used “shortcuts” for estimating DALYs will not, in general, yield accurate estimates of DALY levels nor ICERs in a modeled population.</p>
      </div>
    </div>

    <div>
      <div class="keywords">
        <div class="block-title">Keywords</div>
        <p>Cost-Effectiveness Analysis, Microsimulation, Discrete Event Simulation, Markov Cohort Models</p>
      </div>
    </div>

    <div class="quarto-other-links-text-target">
    </div>  </div>
</header><div id="quarto-content" class="page-columns page-rows-contents page-layout-article toc-left">
<div id="quarto-sidebar-toc-left" class="sidebar toc-left">
  <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#sec-introduction" id="toc-sec-introduction" class="nav-link active" data-scroll-target="#sec-introduction"><span class="header-section-number">1</span> Introduction</a></li>
  <li><a href="#sec-background" id="toc-sec-background" class="nav-link" data-scroll-target="#sec-background"><span class="header-section-number">2</span> Background</a>
  <ul class="collapse">
  <li><a href="#discounting" id="toc-discounting" class="nav-link" data-scroll-target="#discounting"><span class="header-section-number">2.1</span> Discounting</a></li>
  </ul></li>
  <li><a href="#sec-overview" id="toc-sec-overview" class="nav-link" data-scroll-target="#sec-overview"><span class="header-section-number">3</span> Model Overview</a></li>
  <li><a href="#transition-matrices" id="toc-transition-matrices" class="nav-link" data-scroll-target="#transition-matrices"><span class="header-section-number">4</span> Transition Matrices</a>
  <ul class="collapse">
  <li><a href="#approach-1-beginner-cause-specific-death-state" id="toc-approach-1-beginner-cause-specific-death-state" class="nav-link" data-scroll-target="#approach-1-beginner-cause-specific-death-state"><span class="header-section-number">4.1</span> Approach 1 (Beginner): Cause-Specific Death State</a></li>
  <li><a href="#approach-2-intermediate-non-markovian-tracking-states" id="toc-approach-2-intermediate-non-markovian-tracking-states" class="nav-link" data-scroll-target="#approach-2-intermediate-non-markovian-tracking-states"><span class="header-section-number">4.2</span> Approach 2 (Intermediate): Non-Markovian Tracking States</a></li>
  <li><a href="#approach-3-advanced-markov-chain-with-rewards" id="toc-approach-3-advanced-markov-chain-with-rewards" class="nav-link" data-scroll-target="#approach-3-advanced-markov-chain-with-rewards"><span class="header-section-number">4.3</span> Approach 3 (Advanced): Markov Chain With Rewards</a></li>
  </ul></li>
  <li><a href="#sec-outcomes" id="toc-sec-outcomes" class="nav-link" data-scroll-target="#sec-outcomes"><span class="header-section-number">5</span> DALY Outcomes Under Approaches 1 and 2</a>
  <ul class="collapse">
  <li><a href="#markov-trace" id="toc-markov-trace" class="nav-link" data-scroll-target="#markov-trace"><span class="header-section-number">5.1</span> Markov Trace</a></li>
  <li><a href="#years-of-life-lived-with-disability-yld" id="toc-years-of-life-lived-with-disability-yld" class="nav-link" data-scroll-target="#years-of-life-lived-with-disability-yld"><span class="header-section-number">5.2</span> Years of Life Lived with Disability (YLD)</a></li>
  <li><a href="#years-of-life-lost-to-disease-ylls-approach-1" id="toc-years-of-life-lost-to-disease-ylls-approach-1" class="nav-link" data-scroll-target="#years-of-life-lost-to-disease-ylls-approach-1"><span class="header-section-number">5.3</span> Years of Life Lost to Disease (YLLs): Approach 1</a></li>
  <li><a href="#years-of-life-lost-to-disease-ylls-approach-2" id="toc-years-of-life-lost-to-disease-ylls-approach-2" class="nav-link" data-scroll-target="#years-of-life-lost-to-disease-ylls-approach-2"><span class="header-section-number">5.4</span> Years of Life Lost to Disease (YLLs): Approach 2</a></li>
  </ul></li>
  <li><a href="#sec-outcomes3" id="toc-sec-outcomes3" class="nav-link" data-scroll-target="#sec-outcomes3"><span class="header-section-number">6</span> DALY Outcomes Under Approach 3</a>
  <ul class="collapse">
  <li><a href="#years-of-life-lived-with-disease-yld" id="toc-years-of-life-lived-with-disease-yld" class="nav-link" data-scroll-target="#years-of-life-lived-with-disease-yld"><span class="header-section-number">6.1</span> Years of Life Lived With Disease (YLD)</a></li>
  <li><a href="#years-of-life-lost-to-disease-yll" id="toc-years-of-life-lost-to-disease-yll" class="nav-link" data-scroll-target="#years-of-life-lost-to-disease-yll"><span class="header-section-number">6.2</span> Years of Life Lost to Disease (YLL)</a></li>
  <li><a href="#sec-expected" id="toc-sec-expected" class="nav-link" data-scroll-target="#sec-expected"><span class="header-section-number">6.3</span> Expected YLD and YLL Outcomes</a></li>
  </ul></li>
  <li><a href="#sec-results" id="toc-sec-results" class="nav-link" data-scroll-target="#sec-results"><span class="header-section-number">7</span> Results</a>
  <ul class="collapse">
  <li><a href="#comparison-of-daly-outcomes-under-all-three-approaches" id="toc-comparison-of-daly-outcomes-under-all-three-approaches" class="nav-link" data-scroll-target="#comparison-of-daly-outcomes-under-all-three-approaches"><span class="header-section-number">7.1</span> Comparison of DALY Outcomes Under All Three Approaches</a></li>
  <li><a href="#comparison-with-shortcut-based-daly-approaches" id="toc-comparison-with-shortcut-based-daly-approaches" class="nav-link" data-scroll-target="#comparison-with-shortcut-based-daly-approaches"><span class="header-section-number">7.2</span> Comparison with “Shortcut-based” DALY Approaches</a></li>
  </ul></li>
  <li><a href="#discussion" id="toc-discussion" class="nav-link" data-scroll-target="#discussion"><span class="header-section-number">8</span> Discussion</a></li>
  <li><a href="#references" id="toc-references" class="nav-link" data-scroll-target="#references">References</a></li>
  </ul>
<div class="quarto-alternate-notebooks"><h2>Notebooks</h2><ul><li><a href="index-preview.html"><i class="bi bi-journal-code"></i>Article Notebook</a></li><li><a href="notebooks/FRH-replication-preview.html"><i class="bi bi-journal-code"></i>Replicating FRH</a></li></ul></div></nav>
</div>
<div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
</div>
<main class="content quarto-banner-title-block" id="quarto-document-content">



  


<section id="sec-introduction" class="level2" data-number="1">
<h2 data-number="1" class="anchored" data-anchor-id="sec-introduction"><span class="header-section-number">1</span> Introduction</h2>
<div class="callout callout-style-simple callout-tip no-icon">
<div class="callout-body d-flex">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-body-container">
<p>Support for this work is graciously acknowledged from the <a href="https://www.d4hdataimpact.org/data-to-policy">Data to Policy</a> program administered by Vital Strategies and the CDC Foundation with funding from the Bloomberg Philanthropies Data for Health Initiative</p>
</div>
</div>
</div>
<p>Disability-adjusted life years (DALYs) measure disease burden in a population. Conceptualized in the Global Burden of Disease (GBD) study <span class="citation" data-cites="Murray1997">(<a href="#ref-Murray1997" role="doc-biblioref">C. J. Murray and Lopez 1997</a>)</span>, DALYs quantify the total sum of years of life lost due to disability attributable to a disease (YLD), plus years of life lost to premature mortality from the disease (YLL; i.e., DALY = YLD + YLL).</p>
<p>In addition to their role in describing levels and trends in disease burdens worldwide, DALYs are a primary health outcome in evaluations of health interventions in low- and middle-income countries (LMICs). In these settings, resource allocation decisions are guided by modeled assessments of the incremental costs per DALY averted under alternative (often competing) strategies to improve population health.<a href="#fn1" class="footnote-ref" id="fnref1" role="doc-noteref"><sup>1</sup></a></p>
<p>Despite the prominent role of DALYs in global health policy, scant methodological guidance is available for adapting and/or structuring decision analytic models for DALY outcomes. This methodological gap has its roots in health economics education, where textbooks and training exercises focus almost exclusively on Quality-Adjusted Life Year (QALY) outcomes—the primary health outcome used for health technology assessments (HTAs) and policy decisionmaking in high-income countries (HICs). DALYs differ from QALYs in important and model-relevant respects, including the use of reference life tables to calculate YLLs and standardized disability weights to calculate YLDs.<a href="#fn2" class="footnote-ref" id="fnref2" role="doc-noteref"><sup>2</sup></a> To the extent DALY-specific modeling considerations are taught, they are often considered in isolation and without a firm methodological grounding in <em>how</em> one might structure a model to measure DALY outcomes.</p>
<p>As a consequence, and in practice, health economic applications often resort to shortcuts and other “hacks” for calculating DALYs. For example, practitioners may simply estimate a “QALY-like” DALY that is based on a diseased state occupancy payoff of one minus the disability weight. Other approaches define a diseased-state payoff using the disability weight as an estimate of YLDs, and accumulate person-years in an absorbing death state (due to disease) as an estimate of YLLs. As this study will show, these shortcuts do not provide an accurate representation of DALY levels in a population.</p>
<p>This study outlines methods for direct incorporation of DALY outcomes in common decision modeling environments. Our primary focus is on discrete-time Markov cohort models—however, our framework extends directly to microsimulation and is also easily adapted for continuous time discrete event simulation (DES) models. As such, our study provides a comprehensive roadmap for incorporating DALY outcomes into common decision modeling frameworks.</p>
<p>To maintain consistency within the literature, we build on an existing didactic disease progression model <span class="citation" data-cites="alarid2023introductory">(<a href="#ref-alarid2023introductory" role="doc-biblioref">Alarid-Escudero et al. 2023</a>)</span>. The underlying discrete time Markov cohort model is time homogeneous—that is, transition probabilities do not vary as a function of age/time in model. However, our methods and code are developed to accommodate time-inhomogeneous models. Finally, recognizing the wide spectrum of experience and programming comfort level among practitioners, we offer three approaches for modeling DALYs (beginner, intermediate and advanced) and provide replication materials for implementing our approaches in R and Microsoft Excel.</p>
</section>
<section id="sec-background" class="level2" data-number="2">
<h2 data-number="2" class="anchored" data-anchor-id="sec-background"><span class="header-section-number">2</span> Background</h2>
<p>This section provides background information sufficient for conceptual understanding of DALYs and how to estimate them in a decision-analytic model; it is not intended as a comprehensive treatment of the subject. For extensive discussion of the history, assumptions and controversies around DALYs, see TK.</p>
<p>DALYs are the sum of two components: a morbidity component called years lost to disability (YLD), and a premature mortality component called years of life lost to disease (YLL) <span class="citation" data-cites="who2020methods">(<a href="#ref-who2020methods" role="doc-biblioref">WHO 2013</a>)</span>. To quantify YLDs, conditions are assigned disability weights (<span class="math inline">\(D\)</span>) ranging from zero to one, with zero representing the absence of the condition and one representing the highest burden a condition can inflict. Disability weights are elicited from expert panels, are standardized across geographies, and are routinely updated and published as part of the GBD <span class="citation" data-cites="who2020methods">(<a href="#ref-who2020methods" role="doc-biblioref">WHO 2013</a>)</span>.</p>
<p>For a given condition <span class="math inline">\(c\)</span>, YLDs are defined as the condition’s disability weight multiplied by the average number of years a person lives with the disease (<span class="math inline">\(L_c\)</span>):</p>
<p><span id="eq-yld1"><span class="math display">\[
YLD(c) = D_c \cdot L_c
\tag{1}\]</span></span></p>
<p>YLLs are determined by a loss function, which is typically defined as the number of years lost to premature mortality. This value is often taken from a life table that provides information on remaining life expectancy at age <span class="math inline">\(a\)</span>,</p>
<p><span id="eq-yll1"><span class="math display">\[
YLL(a)= Ex(a)
\tag{2}\]</span></span> .</p>
<p>Choices over the specific value of remaining life expectancy will depend on the context and research question at hand <span class="citation" data-cites="anand2019">(<a href="#ref-anand2019" role="doc-biblioref">Anand and Reddy 2019</a>)</span>. Historically, the GBD has utilized an <em>exogenous</em>, external reference life table based on the maximum potential life span among humans <span class="citation" data-cites="who2020methods globalburdenofdiseasecollaborativenetwork2021">(<a href="#ref-who2020methods" role="doc-biblioref">WHO 2013</a>; <a href="#ref-globalburdenofdiseasecollaborativenetwork2021" role="doc-biblioref">Global Burden of Disease Collaborative Network 2021</a>)</span>. More recent GBD estimates draw on reference life tables based on the lowest observed age-specific mortality rates among geographies with populations over 5 million in 2016 <span class="citation" data-cites="globalburdenofdiseasecollaborativenetwork2021">(<a href="#ref-globalburdenofdiseasecollaborativenetwork2021" role="doc-biblioref">Global Burden of Disease Collaborative Network 2021</a>)</span>.</p>
<p>Finally, DALYS are simply the sum of these two components:</p>
<p><span id="eq-daly"><span class="math display">\[
DALY(c,a) = YLD(c) + YLL(a)
\tag{3}\]</span></span></p>
<section id="discounting" class="level3" data-number="2.1">
<h3 data-number="2.1" class="anchored" data-anchor-id="discounting"><span class="header-section-number">2.1</span> Discounting</h3>
<p>In the original GBD study, additional age-weighting and time discounting practices were applied to DALY calculations <span class="citation" data-cites="Murray1997">(<a href="#ref-Murray1997" role="doc-biblioref">C. J. Murray and Lopez 1997</a>)</span>. These methods respectively weighted the burden of illness more during adulthood than early childhood and old age, and valued present health over future years of illness by discounting YLD and YLL measures by 3% per year. From 2010 onwards, both practices were discontinued to make the DALY a more descriptive measure <span class="citation" data-cites="who2020methods">(<a href="#ref-who2020methods" role="doc-biblioref">WHO 2013</a>)</span>.</p>
<p>While the GBD no longer uses age and time discounting, the World Health Organization’s Choosing Interventions that are Cost-Effective (WHO-CHOICE) program recommends consideration of time discounting of health outcomes <span class="citation" data-cites="murray2020 bertram2021">(<a href="#ref-murray2020" role="doc-biblioref">C. J. L. Murray et al. 2020</a>; <a href="#ref-bertram2021" role="doc-biblioref">Bertram et al. 2021</a>)</span>. We therefore adopt the WHO-CHOICE recommendation and include discounting in our DALY modeling approach.<a href="#fn3" class="footnote-ref" id="fnref3" role="doc-noteref"><sup>3</sup></a> We do, however, maintain the continuous-time discounting used in the original GBD DALY equations—which differs slightly from the more common use of discrete time discounting in Markov cohort models.</p>
<p>For an annual discount rate <span class="math inline">\(r\)</span>, for condition <span class="math inline">\(c\)</span>, and at age <span class="math inline">\(a\)</span>, the equation for YLDs is,</p>
<p><span id="eq-yld"><span class="math display">\[
YLD(c) = D_c  \left ( \frac{1}{r}\left(1-e^{-r(L_c) }\right) \right ).
\tag{4}\]</span></span></p>
<p>Similarly, YLLs are calculated as,</p>
<p><span id="eq-yll"><span class="math display">\[
YLL(a)= \frac{1}{r}\left(1-e^{-r Ex(a)}\right).
\tag{5}\]</span></span></p>
<p>It is important to note that the discounting shown in <a href="#eq-yld" class="quarto-xref">Equation&nbsp;4</a> and <a href="#eq-yll" class="quarto-xref">Equation&nbsp;5</a> yields the present value of YLD and YLL outcomes at a single point in time, when the duration of disease (<span class="math inline">\(L_c\)</span>) and time of death from disease (<span class="math inline">\(a\)</span>) are known. For a decision model where not all cohort members start off ill, that point in time very likely occurs at some point after the baseline period—and different illness durations and death times will, of course, occur across individuals in a modeled cohort. As such, we must discount YLL and YLD outcomes further, to time <span class="math inline">\(t=0\)</span> period. This additional discounting step will become apparent in <a href="#sec-outcomes" class="quarto-xref">Section&nbsp;5</a> below.</p>
</section>
</section>
<section id="sec-overview" class="level2" data-number="3">
<h2 data-number="3" class="anchored" data-anchor-id="sec-overview"><span class="header-section-number">3</span> Model Overview</h2>
<p>We build on an existing progressive disease model in which healthy individuals develop a disease with two health states (“Sick” and “Sicker”; <span class="citation" data-cites="alarid2023introductory">Alarid-Escudero et al. (<a href="#ref-alarid2023introductory" role="doc-biblioref">2023</a>)</span>). Individuals can also transition to an absorbing death state due to causes unrelated to the disease (i.e., “background” mortality), or due to disease-specific causes.</p>
<p>We consider outcomes under four strategies:</p>
<ul>
<li>A <strong>Standard of Care</strong> strategy based on the baseline model parameters.</li>
<li><strong>Strategy A</strong>, which improves the quality of life among individuals with the disease, but does not affect disease progression.</li>
<li><strong>Strategy B</strong>, which reduces the rate of progression from Sick to Sicker by 40%.</li>
<li><strong>Composite Strategy AB</strong>, which jointly implements strategies A and B.</li>
</ul>
<p>A state transition diagram is shown in <a href="#fig-model1" class="quarto-xref">Figure&nbsp;1</a>. In the figure, nodes are health states and edges depict transitions among them. Edge labels are defined in terms of transition intensities (rates). Other key model parameters are summarized in <a href="#tbl-params" class="quarto-xref">Table&nbsp;1</a>.</p>
<p>As depicted in <a href="#fig-model1" class="quarto-xref">Figure&nbsp;1</a>, and as parameterized in our replication code, the underlying Markov model is time homogeneous—that is, transition rates do not vary as a function of age/time. This is merely a simplification that builds on an existing time-homogeneous model constructed for didactic purposes <span class="citation" data-cites="alarid2023introductory">(<a href="#ref-alarid2023introductory" role="doc-biblioref">Alarid-Escudero et al. 2023</a>)</span>. We do, however, index all formulas and other model-relevant objects with the subscript <span class="math inline">\(t\)</span> to allow for time-inhomogenous models. Our replication code is also written to accommodate time-inhomogeneous models.</p>
<p>An additional assumption is worth highlighting. In our model, disability weights are defined as one minus the utility weight. This is not generally the case, as DALY disability weights are derived from expert valuations and are standardized across countries and regions <span class="citation" data-cites="who2020methods sassi2006calculating">(<a href="#ref-who2020methods" role="doc-biblioref">WHO 2013</a>; <a href="#ref-sassi2006calculating" role="doc-biblioref">Sassi 2006</a>)</span>. Utility weights, by contrast, are often derived from general population and/or patient samples and therefore differ across geographies <span class="citation" data-cites="sassi2006calculating">(<a href="#ref-sassi2006calculating" role="doc-biblioref">Sassi 2006</a>)</span>. We have elected to parameterize our model in this way to hold this methodological difference fixed—that is, we aim to show how differences in methodological choices shape estimates of DALYs while holding fixed <em>additional</em> differences that might occur due to differences in the derivation of disability and utility weights.</p>
<div id="fig-model1" class="quarto-figure quarto-figure-center quarto-float anchored">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-model1-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/state-transition-diagram-1.svg" class="lightbox" data-glightbox="description: .lightbox-desc-1" data-gallery="quarto-lightbox-gallery-1"><img src="images/state-transition-diagram-1.svg" class="img-fluid figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-model1-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;1: State transition diagram for progressive disease model
</figcaption>
</figure>
</div>
<div class="cell">
<div id="tbl-params" class="cell quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-params-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;1: Model Parameters
</figcaption>
<div aria-describedby="tbl-params-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<div class="cell-output-display">
<div class="tabwid"><style>.cl-f2e86aee{}.cl-f2e4eb58{font-family:'Helvetica';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-f2e672e8{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-f2e67cf2{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f2e67cf3{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f2e67cf4{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f2e67cfc{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(255, 255, 255, 0.00);border-top: 0 solid rgba(255, 255, 255, 0.00);border-left: 0 solid rgba(255, 255, 255, 0.00);border-right: 0 solid rgba(255, 255, 255, 0.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing="true" class="cl-f2e86aee"><thead><tr style="overflow-wrap:break-word;"><th class="cl-f2e67cf2"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Parameter Name</span></p></th><th class="cl-f2e67cf2"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Value</span></p></th><th class="cl-f2e67cf2"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Description</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">v_tx_names</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">(SoC,A,B,AB)'</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Treatment strategies (vector)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">n_tx</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">4</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Number of treatment strategies</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">cycle_correction</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">half-cycle</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle correction method</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">v_tr_names</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">(H,S1,S2)'</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Transient health state names (vector)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">v_ab_names</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">(DOC,DS)'</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Absorbing health state names (vector)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">n_states</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">5</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Total number of health states</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">horizon</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">500</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Model time horizon (years)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">r_v_disc_h</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.03</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Annual discount rate for health outcomes</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">r_v_disc_c</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.03</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Annual discount rate for cost outcomes</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Delta_t</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Time step (cycle length; 1=annual, 1/12=monthly, etc.)</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">age0</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">25</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Age at baseline</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">r_HS1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.15</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Transition rate: healthy to sick</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">r_S1H</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.5</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Transition rate: sick to healthy</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">r_S1S2</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.105</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Transition rate: sick to sicker</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">r_HD</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.002</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Transition rate: Disease-free background mortality</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">hr_S1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">3</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Hazard ratio: mortality from sick state</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">hr_S2</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">10</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Hazard ratio: mortality from sicker state</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">u_H</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Utility weight: healthy [H]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">u_S1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.75</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Utility weight: sick [S1]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">u_S2</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.5</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Utility weight: sick [S2]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">u_D</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Utility weight: death [D]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">dw_S1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.25</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Disability weight: sick [S1]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">dw_S2</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.5</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Disability weight: sicker [S2]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">c_H</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">2000</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle occupancy cost: healthy [H]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">c_S1</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">4000</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle occupancy cost: sick [S1]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">c_S2</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">15000</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle occupancy cost: sicker [S2]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">c_D</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle occupancy cost: death [D]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">c_trtA</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">12000</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle occupancy cost: treatment A [S1,S2]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">u_trtA</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.95</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Utility weight: treatment A [S1]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">dw_trtA</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.05</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Disbility weight: treatment A [S1]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">c_trtB</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">12000</span></p></td><td class="cl-f2e67cf3"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Cycle occupancy cost: treatment B [S1,S2]</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f2e67cf4"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">hr_S1S2_trtB</span></p></td><td class="cl-f2e67cf4"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">0.6</span></p></td><td class="cl-f2e67cf4"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Hazard Ratio: S1 to S2 disease progression under treatment B</span></p></td></tr></tbody><tfoot><tr style="overflow-wrap:break-word;"><td colspan="3" class="cl-f2e67cfc"><p class="cl-f2e672e8"><span class="cl-f2e4eb58">Source: Alarid-Escudero et al. (2023) and authors' assumptions.</span></p></td></tr></tfoot></table></div>
</div>
</div>
</figure>
<a class="quarto-notebook-link" id="nblink-2" href="index-preview.html#tbl-params">Source: Article Notebook</a></div>
<a class="quarto-notebook-link" id="nblink-1" href="index-preview.html">Source: Article Notebook</a></div>
</section>
<section id="transition-matrices" class="level2" data-number="4">
<h2 data-number="4" class="anchored" data-anchor-id="transition-matrices"><span class="header-section-number">4</span> Transition Matrices</h2>
<p>With the model parameterized, we next define the matrices that govern transitions. The state transition diagram represented in <a href="#fig-model1" class="quarto-xref">Figure&nbsp;1</a> is not yet well-suited to calculate DALY outcomes, however. A primary reason is that transitions to the absorbing death state capture transitions due to all causes of death. To calculate YLLs, we must separately track the timing and number of deaths <em>due to disease</em>.</p>
<p>To accommodate this need, several approaches are available. We categorize each based on the level of experience and skill required (beginner, intermediate, advanced):</p>
<ol type="1">
<li><p><strong>Approach 1 (Beginner): Separate Death State</strong>: Re-define the health states to include a separate cause-specific death state as depicted in <a href="#fig-modelDS" class="quarto-xref">Figure&nbsp;2</a>.<a href="#fn4" class="footnote-ref" id="fnref4" role="doc-noteref"><sup>4</sup></a> We then construct a Markov trace tracking state occupancy in each cycle, and use changes in the number of cause-specific deaths across cycles to calculate YLLs.</p></li>
<li><p><strong>Approach 2 (Intermediate): Non-Markovian Trackers</strong>: Augment the transition matrices to include a non-Markovian transition state for cause-specific deaths. This approach allows for efficient calculation of YLD, YLL and DALY outcomes (often useful for microsimulation or probabilistic sensitivity analyses) because it sidesteps the need to derive a Markov trace.</p></li>
<li><p><strong>Approach 3 (Advanced): Markov Chain with Rewards</strong> Define a block matrix Markov chain with rewards for occupancy (YLDs) and disease-related death transitions (YLLs) by adapting the methods in <span class="citation" data-cites="caswell2021a">Caswell and van Daalen (<a href="#ref-caswell2021a" role="doc-biblioref">2021</a>)</span>. This approach is the most efficient since it solves directly for expected outcomes; it also facilitates estimation of higher order moments such as variance and skewness of DALYs in a population.</p></li>
</ol>
<p>Each approach facilitates the design and execution of a decision-analytic model that correctly calculates YLD, YLL, and DALY outcomes—as well as other common outcomes such as life-years (LYs), QALYs and costs. In practice, Approaches (1) and (2) will produce identical results. Approach (3) draws on slightly different assumptions on partial health state occupancy in a cycle, but yields results quite similar to (1) and (2). We show in <a href="#sec-results" class="quarto-xref">Section&nbsp;7</a> that other shortcut-based approaches previously used in the literature—such as modeling a QALY-like DALY and/or accumulating time in the absorbing death state—will not in general yield similar results.</p>
<section id="approach-1-beginner-cause-specific-death-state" class="level3" data-number="4.1">
<h3 data-number="4.1" class="anchored" data-anchor-id="approach-1-beginner-cause-specific-death-state"><span class="header-section-number">4.1</span> Approach 1 (Beginner): Cause-Specific Death State</h3>
<p>Under this approach, we separate out deaths from disease vs.&nbsp;other causes by defining a separate health state for cause-specific mortality; <a href="#fig-modelDS" class="quarto-xref">Figure&nbsp;2</a> shows an updated state transition diagram.</p>
<div id="fig-modelDS" class="quarto-figure quarto-figure-center quarto-float anchored">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-modelDS-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/state-transition-diagram-2.svg" class="lightbox" data-glightbox="description: .lightbox-desc-2" data-gallery="quarto-lightbox-gallery-2"><img src="images/state-transition-diagram-2.svg" class="img-fluid figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-modelDS-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;2: State transition diagram for progressive disease model with separate cause-specific death state
</figcaption>
</figure>
</div>
<p>Transitions among health states are defined in terms of continuous rates (“intensities”) and are captured within an intensity matrix <span class="math inline">\(\mathbf{Q}_t\)</span>,</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/Q_model2.png" class="lightbox" data-glightbox="description: .lightbox-desc-3" data-gallery="quarto-lightbox-gallery-3" title="Transition Intensity Matrix for Approach 1"><img src="images/Q_model2.png" class="img-fluid figure-img" alt="Transition Intensity Matrix for Approach 1"></a></p>
<figcaption>Transition Intensity Matrix for Approach 1</figcaption>
</figure>
</div>
<p>Cell values in row <span class="math inline">\(i\)</span>, column <span class="math inline">\(j\)</span> of <span class="math inline">\(\mathbf{Q}_t\)</span> capture the (continuous time) transition rate from health state <span class="math inline">\(i\)</span> to health state <span class="math inline">\(j\)</span>. <span class="math inline">\(\mathbf{Q}_t\)</span> has diagonal elements defined as the negative sum of the off-diagonal row values (i.e., the row sums of <span class="math inline">\(\mathbf{Q}_t\)</span> are zero). This ensures that the Markov model is “closed”—that is, the total cohort size neither grows or shrinks over time.</p>
<p>We next embed the transition intensity matrix into a discrete time transition probability matrix by taking the matrix exponential of <span class="math inline">\(\mathbf{Q}_t\)</span> for a defined cycle length (“time step”) <span class="math inline">\(\Delta t\)</span>:<a href="#fn5" class="footnote-ref" id="fnref5" role="doc-noteref"><sup>5</sup></a></p>
<p><span id="eq-embed"><span class="math display">\[
\mathbf{P}_t = e^{\mathbf{Q}_t\Delta t}
\tag{6}\]</span></span></p>
<p>Embedding the Sick-Sicker model results in a transition probability matrix <span class="math inline">\(\mathbf{P}_t\)</span> with the following probabilities defined:</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/P_model2.png" class="lightbox" data-glightbox="description: .lightbox-desc-4" data-gallery="quarto-lightbox-gallery-4" title="Transition Probability Matrix for Approach 1"><img src="images/P_model2.png" class="img-fluid figure-img" style="width:60.0%" alt="Transition Probability Matrix for Approach 1"></a></p>
<figcaption>Transition Probability Matrix for Approach 1</figcaption>
</figure>
</div>
<p>Embedding the transition probability matrix using <a href="#eq-embed" class="quarto-xref">Equation&nbsp;6</a> ensures that the resulting transition probabilities capture the underlying continuous time disease process. In particular, <span class="math inline">\(\mathbf{P}\)</span> captures the probability of compound (“jumpover”) transitions within a single cycle.<a href="#fn6" class="footnote-ref" id="fnref6" role="doc-noteref"><sup>6</sup></a></p>
</section>
<section id="approach-2-intermediate-non-markovian-tracking-states" class="level3" data-number="4.2">
<h3 data-number="4.2" class="anchored" data-anchor-id="approach-2-intermediate-non-markovian-tracking-states"><span class="header-section-number">4.2</span> Approach 2 (Intermediate): Non-Markovian Tracking States</h3>
<p>This method maintains the overall structure as depicted in the original <a href="#fig-model1" class="quarto-xref">Figure&nbsp;1</a>, but augments the transition probability matrix with non-Markovian components to facilitate accounting of disease-related deaths.<a href="#fn7" class="footnote-ref" id="fnref7" role="doc-noteref"><sup>7</sup></a> Approach 2 offers a more generalized method that allows practitioners to accurately account for costs and/or health payoffs (such as YLLs) that are defined by <em>transitions</em> among health states, rather than occupancy in a health state. DALY outcomes can also be calculated directly, without the need to derive a vector of disease-related death transitions from the Markov trace (as required for Approach 1).</p>
<p><a href="#fig-transition" class="quarto-xref">Figure&nbsp;3</a> shows a state transition diagram with the tracking state added. The tracking state (shown as red nodes) simply records transitions as cohort members move from either diseased state to the absorbing death state due to causes related to the disease.</p>
<div id="fig-transition" class="quarto-figure quarto-figure-center quarto-float anchored">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-transition-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/state-transition-diagram-3.svg" class="lightbox" data-glightbox="description: .lightbox-desc-5" data-gallery="quarto-lightbox-gallery-5"><img src="images/state-transition-diagram-3.svg" class="img-fluid figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-transition-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;3: State Transition Diagram with Transition State (Red)
</figcaption>
</figure>
</div>
<p>In general, tracking states can either count the total number of transitions that have occurred up to a given cycle (i.e., an “accumulator” state), or can track the total number of new transitions that occur within a single cycle (i.e., a “transition” state).<a href="#fn8" class="footnote-ref" id="fnref8" role="doc-noteref"><sup>8</sup></a> To calculate YLL outcomes we will add a transition state that records the total number of new disease-related deaths in each cycle.</p>
<p>To implement Approach 2, we add a transition state row and column to the transition intensity matrix. This transition state, called <span class="math inline">\(\texttt{trDS}\)</span>, is included in the augmented intensity matrix <span class="math inline">\(\mathbf{Q}_t\)</span> below:</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/Q_model1.png" class="lightbox" data-glightbox="description: .lightbox-desc-6" data-gallery="quarto-lightbox-gallery-6" title="Transition intensity matrix with transition state added"><img src="images/Q_model1.png" class="img-fluid figure-img" alt="Transition intensity matrix with transition state added"></a></p>
<figcaption>Transition intensity matrix with transition state added</figcaption>
</figure>
</div>
<p>Two aspects of <span class="math inline">\(\mathbf{Q}_t\)</span> are worth highlighting. First, <span class="math inline">\(\mathbf{Q}_t\)</span> is divided into a Markovian submatrix and the non-Markovian tracking row and column. This division is made apparent using dotted vertical and horizontal lines. Critically, the Markovian submatrix remains closed—that is, the diagonal elements remain unchanged so that the row sums of the submatrix remain zero, even after the addition of the tracking column along the “edges” of <span class="math inline">\(\mathbf{Q}_t\)</span>. This ensures that the Markovian submatrix can be used to calculate state occupancy for a closed cohort that neither gains nor loses cohort members over time.</p>
<p>Second, two transition intensities—from the S1 (Sick) and S2 (Sicker) states to Death—appear in the tracking column. This ensures that <span class="math inline">\(\texttt{trDeadDisease}\)</span> will track all relevant transitions to death due to the disease. Because we are operating on the rate scale, we can net out non-disease related deaths as captured by the background mortality rate among healthy individuals (i.e., <span class="math inline">\(\texttt{r\_HD}\)</span>). Other approaches might draw on cause-deleted life tables to incorporate death transition rates that net out deaths from the disease itself.<a href="#fn9" class="footnote-ref" id="fnref9" role="doc-noteref"><sup>9</sup></a></p>
<p>As above, we obtain the transition probability matrix by embedding <span class="math inline">\(\mathbf{Q}_t\)</span> into the discrete time step (<a href="#eq-embed" class="quarto-xref">Equation&nbsp;6</a>). However, the resulting transition probability matrix treats <span class="math inline">\(\texttt{trDS}\)</span> as an absorbing state (i.e., individuals are retained in <span class="math inline">\(\texttt{trDS}\)</span> with probability one). Using the terminology introduced above, this absorbing state could serve as an <strong>accumulator</strong> state that (in the constructed Markov trace) records the total number of people who have died from the disease up to any given cycle. This may be a decision-relevant health outcome to consider on its own; indeed, so long as the Markovian submatrix remains closed, there is no limit to the number of accumulator and/or transition states one might add along the “edges” of a model.<a href="#fn10" class="footnote-ref" id="fnref10" role="doc-noteref"><sup>10</sup></a></p>
<p>To change <span class="math inline">\(\texttt{trDS}\)</span> to a <strong>transition</strong> state, we simply replace the absorbing probability of one in the cell <span class="math inline">\([\texttt{trDS},\texttt{trDS}]\)</span> with a zero. This cell-level change is highlighted in grey in the bottom right cell of <span class="math inline">\(\mathbf{P}\)</span> below:</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/P_model1.png" class="lightbox" data-glightbox="description: .lightbox-desc-7" data-gallery="quarto-lightbox-gallery-7" title="Transition Probability Matrix for Approach 2"><img src="images/P_model1.png" class="img-fluid figure-img" style="width:60.0%" alt="Transition Probability Matrix for Approach 2"></a></p>
<figcaption>Transition Probability Matrix for Approach 2</figcaption>
</figure>
</div>
</section>
<section id="approach-3-advanced-markov-chain-with-rewards" class="level3" data-number="4.3">
<h3 data-number="4.3" class="anchored" data-anchor-id="approach-3-advanced-markov-chain-with-rewards"><span class="header-section-number">4.3</span> Approach 3 (Advanced): Markov Chain With Rewards</h3>
<p>Our final approach adapts methods from mathematical demography to estimate YLD, YLL and DALY outcomes <span class="citation" data-cites="caswell2021a">(<a href="#ref-caswell2021a" role="doc-biblioref">Caswell and van Daalen 2021</a>)</span>.<a href="#fn11" class="footnote-ref" id="fnref11" role="doc-noteref"><sup>11</sup></a> This approach requires a separate disease-related absorbing state as shown in <a href="#fig-modelDS" class="quarto-xref">Figure&nbsp;2</a>. While our focus here is on expected outcomes, this method can also be used to estimate higher order moments (e.g., variance, skewness). It is also quite flexible and can estimate separate outcomes for any combination of health states and age classes (e.g., disease-free survival among those aged 40-45, etc.); see <span class="citation" data-cites="caswell2018">Caswell and Zarulli (<a href="#ref-caswell2018" role="doc-biblioref">2018</a>)</span> and <span class="citation" data-cites="caswell2021a">Caswell and van Daalen (<a href="#ref-caswell2021a" role="doc-biblioref">2021</a>)</span> for details.</p>
<p>To implement Approach 3 we define some additional parameters:</p>
<p><span class="math display">\[
\begin{aligned}
\tau &amp;= \text{Number of transient (non-absorbing) states}\\
\alpha &amp;= \text{Number of absorbing states}\\
\omega &amp;= \text{Number of cycles (age classes)} \\
s &amp;= \text{Total number of states; }s=\tau\omega+\alpha \\
\mathbf{K} &amp;= \text{vec-permutation matrix; parameters }\tau,\omega\\
\mathbf{U}_{t} &amp;= \text{Transition matrix at time }t, \text{for }t=1,\dots,\omega\\
\mathbf{M}_{t} &amp;= \text{Mortality matrix at time  }t, \text{for } t = 1,\dots\omega \\
\mathbf{D}_{j} &amp;=\text{Age advancement matrix for stage }j, \text{for }j=1,\dots,\tau
\end{aligned}
\]</span> In the above notation, <span class="math inline">\(\mathbf{K}\)</span> is a permutation matrix known as the vec-permutation matrix.<a href="#fn12" class="footnote-ref" id="fnref12" role="doc-noteref"><sup>12</sup></a> The matrix <span class="math inline">\(\mathbf{U}_t\)</span> captures transition probabilities among transient (i.e., non-absorbing) health states, while <span class="math inline">\(\mathbf{M}_t\)</span> contains transition probabilities from transient health states to the absorbing (death) states.</p>
<p>To construct <span class="math inline">\(\mathbf{U}_t\)</span> and <span class="math inline">\(\mathbf{M}_t\)</span> we define transition rate (“intensity”) matrices as in Approaches 1 and 2 above. One important (minor) difference is that the rows in <span class="math inline">\(\mathbf{Q}_t\)</span>, <span class="math inline">\(\mathbf{V}_t\)</span>, and <span class="math inline">\(\mathbf{S}_t\)</span> now correspond to the final state, while the columns correspond to the starting state; this is essentially the transpose of the rate matrices defined for Approaches 1 and 2.</p>
<p>The overall intensity matrix <span class="math inline">\(\mathbf{Q}_t\)</span> is given by</p>
<p><span id="eq-Qx"><span class="math display">\[
\mathbf{Q}_t=\left(\begin{array}{c|c}
\mathbf{V}_t &amp; \mathbf{0} \\
\hline \mathbf{S}_t  &amp; \mathbf{0}
\end{array}\right)
\tag{7}\]</span></span> where <span class="math inline">\(\mathbf{V}_t\)</span> is the rate matrix for the transitory (i.e., non-absorbing) states and <span class="math inline">\(\mathbf{S}_t\)</span> is the rate matrix for the absorbing states. The diagonal elements of <span class="math inline">\(\mathbf{Q}_t\)</span> are the negative sum of the non-diagonal column elements, thus making the column sums of <span class="math inline">\(\mathbf{Q}_t\)</span> zero (i.e., the model is “closed” and does not gain or lose cohort members over time).</p>
<p>For the defined time step <span class="math inline">\(\Delta_t\)</span>, the discrete time transition probability matrix <span class="math inline">\(\mathbf{P}_t\)</span> is again obtained by taking the matrix exponential of the intensity matrix (<span class="math inline">\(\mathbf{Q}_t\)</span>) multiplied by the time step, i.e., <a href="#eq-embed" class="quarto-xref">Equation&nbsp;6</a>:</p>
<p><span class="math display">\[
\mathbf{P}_t =e^{\mathbf{Q}_t  \Delta t}
\]</span></p>
<p>We obtain <span class="math inline">\(\mathbf{U}_t\)</span> and <span class="math inline">\(\mathbf{M}_t\)</span> from the block matrix structure of <span class="math inline">\(\mathbf{P}_t\)</span>:</p>
<p><span id="eq-P3"><span class="math display">\[
\mathbf{P}_t =\left(\begin{array}{c|c}
\mathbf{U}_t  &amp; \mathbf{0} \\
\hline \mathbf{M}_t  &amp; \mathbf{0}
\end{array}\right)
\tag{8}\]</span></span></p>
<p>In addition, the matrix <span class="math inline">\(\mathbf{D}_j\)</span> defines age advancement in the model. Borrowing from an example in <span class="citation" data-cites="caswell2021a">Caswell and van Daalen (<a href="#ref-caswell2021a" role="doc-biblioref">2021</a>)</span>, if <span class="math inline">\(\omega=3\)</span> then</p>
<p><span id="eq-D"><span class="math display">\[
\mathbf{D}_j=\left(\begin{array}{ccc}
0 &amp; 0 &amp; 0 \\
1 &amp; 0 &amp; 0 \\
0 &amp; 1 &amp; {[1]}
\end{array}\right) \quad j=1, \ldots, \tau
\tag{9}\]</span></span></p>
<p>In our implementation, we include the (optional) value of one in the lower right corner; this assumes that after the last specified age, the cohort continues to experience transitions among health states according to the transition probabilities defined for the last age class. If this value is zero, the model will assume that everyone dies after the last cycle.</p>
<p>We next combine the transition matrices (for all age classes as defined by discrete time cycles) together into a series of block-structured matrices as follows:</p>
<p><span id="eq-bbU"><span class="math display">\[
\mathbb{U}=\left(\begin{array}{c|c|c}
\mathbf{U}_1 &amp; \cdots &amp; \mathbf{0} \\
\hline &amp; \ddots &amp; \\
\hline \mathbf{0} &amp; \cdots &amp; \mathbf{U}_\omega
\end{array}\right)
\tag{10}\]</span></span></p>
<p><span id="eq-BBD"><span class="math display">\[
\mathbb{D}=\left(\begin{array}{c|c|c}
\mathbf{D}_1 &amp; \cdots &amp; \mathbf{0} \\
\hline &amp; \ddots &amp; \\
\hline \mathbf{0} &amp; \cdots &amp; \mathbf{D}_\tau
\end{array}\right)
\tag{11}\]</span></span></p>
<p><span id="eq-Utilde"><span class="math display">\[
\widetilde{\mathbf{U}}=\mathbf{K}^{\top} \mathbb{D} \mathbf{K} \mathbb{U} \quad \tau \omega \times \tau \omega
\tag{12}\]</span></span> where <span class="math inline">\(^\top\)</span> is the transpose operator.</p>
<p>We also define</p>
<p><span id="eq-Mtilde"><span class="math display">\[
\widetilde{\mathbf{M}}=\left(\begin{array}{lll}
\mathbf{M}_1 &amp; \cdots &amp; \mathbf{M}_\omega
\end{array}\right) \quad \alpha \times \tau \omega
\tag{13}\]</span></span></p>
<p>Finally, we capture the entire Markov chain in a block transition matrix,</p>
<p><span id="eq-Ptilde"><span class="math display">\[
\widetilde{\mathbf{P}}=\left(\begin{array}{c|c}
\widetilde{\mathbf{U}} &amp; \mathbf{0}_{\tau \omega \times \alpha} \\
\hline \widetilde{\mathbf{M}} &amp; \mathbf{I}_{\alpha \times \alpha}
\end{array}\right) \quad(\tau \omega+\alpha) \times(\tau \omega+\alpha)
\tag{14}\]</span></span> where <span class="math inline">\(\mathbf{I}\)</span> is the identity matrix and <span class="math inline">\(\mathbf{0}\)</span> is a matrix of zeros.</p>
<p><span class="math inline">\(\widetilde{\mathbf{P}}\)</span> is the analogue to the transition matrix <span class="math inline">\(\mathbf{P}_t\)</span> (<a href="#eq-embed" class="quarto-xref">Equation&nbsp;6</a>) under Approaches 1 and 2 above.</p>
</section>
</section>
<section id="sec-outcomes" class="level2" data-number="5">
<h2 data-number="5" class="anchored" data-anchor-id="sec-outcomes"><span class="header-section-number">5</span> DALY Outcomes Under Approaches 1 and 2</h2>
<p>With transition matrices and other relevant model objects defined, we next define formulas for estimating outcomes. Our three approaches differ in how total (or expected) outcomes are calculated. Approach 1 requires a Markov trace that tracks occupancy in each cycle; for YLL outcomes, we use this information to calculate the number of new disease-related deaths in each cycle. Approach 2 does not require this extra step, as both cycle-specific and total outcomes are calculated directly. Finally, Approach 3 differs insofar as it directly solves for expected outcomes (i.e., the approach does not require calculation of cycle-specific values).</p>
<section id="markov-trace" class="level3" data-number="5.1">
<h3 data-number="5.1" class="anchored" data-anchor-id="markov-trace"><span class="header-section-number">5.1</span> Markov Trace</h3>
<p>YLL outcomes calculated under Approach 1 requires a Markov trace, or a matrix summarizing occupancy in each health state in each cycle. Define <span class="math inline">\(\mathbf{s}_0\)</span> as the initial state occupancy (column) vector at time <span class="math inline">\(t=0\)</span>. The vector <span class="math inline">\(\mathbf{s}_0\)</span> has size <span class="math inline">\(k\)</span>, where <span class="math inline">\(k\)</span> is the total number of states (including transition tracking states, if applicable). This vector summarizes the number or fraction of the cohort in each health state at baseline. Health state occupancy at time <span class="math inline">\(t\)</span> is is calculated as:</p>
<p><span id="eq-trace"><span class="math display">\[
\mathbf{s}^\top_t=\mathbf{s}^\top_0 \mathbf{P}_1\mathbf{P}_2\dots\mathbf{P}_t
\tag{15}\]</span></span> where <span class="math inline">\(\mathbf{P}_t\)</span> is the <span class="math inline">\(k \times k\)</span> transition probability matrix at time <span class="math inline">\(t\)</span>.<a href="#fn13" class="footnote-ref" id="fnref13" role="doc-noteref"><sup>13</sup></a></p>
<p>We apply <a href="#eq-trace" class="quarto-xref">Equation&nbsp;15</a> at each cycle to construct a Markov trace <span class="math inline">\(\mathbf{S}\)</span>, which has dimensions <span class="math inline">\(\omega \times k\)</span>,</p>
<p><span id="eq-markovtrace"><span class="math display">\[
\mathbf{S} = \begin{bmatrix}
s_{01} &amp; s_{02} &amp; \ldots &amp; s_{0k} \\
s_{11} &amp; s_{12} &amp; \ldots &amp; s_{1k} \\
\vdots &amp; \vdots &amp; \ddots &amp; \vdots \\
s_{\omega-1, 1} &amp; s_{\omega-1, 2} &amp; \ldots &amp; s_{\omega-1, k}
\end{bmatrix}
\tag{16}\]</span></span> where each row represents state occupancy at time <span class="math inline">\(t = 0, 1, \ldots, \omega-1\)</span>.</p>
<p>Note that the rows in <span class="math inline">\(\mathbf{S}\)</span> run from <span class="math inline">\(t=0\)</span> to <span class="math inline">\(\omega-1\)</span>; this assumes that all health state transitions occur at the end of each cycle. If we were to instead assume transitions occur at the beginning of the cycle, we would set the matrix to run from <span class="math inline">\(t=1\)</span> to <span class="math inline">\(\omega\)</span>.</p>
</section>
<section id="years-of-life-lived-with-disability-yld" class="level3" data-number="5.2">
<h3 data-number="5.2" class="anchored" data-anchor-id="years-of-life-lived-with-disability-yld"><span class="header-section-number">5.2</span> Years of Life Lived with Disability (YLD)</h3>
<p>To calculate YLDs, we define a <span class="math inline">\(k \times 1\)</span> disability weight payoff vector <span class="math inline">\(\mathbf{d}_{YLD}\)</span>. For the model as represented in <a href="#fig-modelDS" class="quarto-xref">Figure&nbsp;2</a>, define,</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/d_yld.png" class="lightbox" data-gallery="quarto-lightbox-gallery-8"><img src="images/d_yld.png" class="img-fluid quarto-figure quarto-figure-center figure-img" style="width:40.0%"></a></p>
</figure>
</div>
<p>where <span class="math inline">\(\texttt{dwS1}\)</span> and <span class="math inline">\(\texttt{dwS2}\)</span> are the disability weights for the Sick and Sicker states, respectively. In addition, <span class="math inline">\(r_{\Delta_t}\)</span> is the cycle discount rate, which is calculated as,</p>
<p><span id="eq-cycledisc"><span class="math display">\[
r_{\Delta_t} = r \Delta_t
\tag{17}\]</span></span> where <span class="math inline">\(r\)</span> is the annual discount rate and <span class="math inline">\(\Delta_t\)</span> is the cycle length.</p>
<p>In the YLD payoff vector, the term <span class="math inline">\(\frac{1}{r_{\Delta_t}}(1-e^{-r_{\Delta_t}})\)</span> is included as a continuous-time discounting factor for the defined time step <span class="math inline">\(\Delta_t\)</span>. This term is included to discount time <em>within</em> each cycle in order to maintain the continuous-time discounting approach used in the original GBD equations <span class="citation" data-cites="larson2013calculating">(<a href="#ref-larson2013calculating" role="doc-biblioref">Larson 2013</a>)</span>.<a href="#fn14" class="footnote-ref" id="fnref14" role="doc-noteref"><sup>14</sup></a></p>
<p>To fully discount outcomes, we still must discount all future outcome values back to baseline (<span class="math inline">\(t=0\)</span>). Discounted years of life lost to disability (YLD) at cycle <span class="math inline">\(t\)</span> is given by</p>
<p><span id="eq-yldt"><span class="math display">\[
YLD_t=\mathbf{s}'_0 \mathbf{P}_1\mathbf{P}_2\dots\mathbf{P}_t \mathbf{d}_{YLD}  \times{e^{-r_{\Delta_t} t}}
\tag{18}\]</span></span></p>
<p>Total discounted YLDs are obtained by summing cycle-specific discounted YLD outcomes,</p>
<p><span id="eq-yldcum"><span class="math display">\[
YLD=\sum_{t=0}^{\omega-1} YLD_t
\tag{19}\]</span></span></p>
<p>We can incorporate additional cycle adjustments (e.g., half-cycle adjustment or an adjustment based on Simpson’s rule) by defining a adjustment factor <span class="math inline">\(c_t\)</span> that multiplies the cycle-specific discounting factor (i.e., <span class="math inline">\(e^{-r_{\Delta_t} t}\)</span>) with other cycle-specific adjustment values,</p>
<p><span id="eq-yldcum2"><span class="math display">\[
YLD=\sum_{t=0}^{\omega-1} YLD(t)=\sum_{t=0}^{\omega-1}\left(\mathbf{s}'_0 \mathbf{P}_1\mathbf{P}_2\dots\mathbf{P}_t \mathbf{d}_{YLD}  \times c_t \right)
\tag{20}\]</span></span> where, at a minimum, <span class="math inline">\(c_t=e^{-r\Delta_t t}\)</span> and can also include any other cycle-correction value (e.g., 0.5 for half-cycle correction or a Simpson’s rule coefficient, etc.).</p>
<p>Finally, an equivalent way to calculate YLD outcomes is through matrix multiplication of the Markov trace matrix and the YLD payoff vector,</p>
<p><span id="eq-yldtrace"><span class="math display">\[
YLD = \sum_{t=0}^{\omega-1} \mathbf{S}\mathbf{d}_{YLD} \odot \mathbf{c}
\tag{21}\]</span></span> where <span class="math inline">\(\mathbf{c}\)</span> is an <span class="math inline">\(\omega \times 1\)</span> vector of cycle discounting/correction factors <span class="math inline">\(c_t\)</span> and <span class="math inline">\(\odot\)</span> is the element-wise multiplication (Hadamard product) operator.</p>
</section>
<section id="years-of-life-lost-to-disease-ylls-approach-1" class="level3" data-number="5.3">
<h3 data-number="5.3" class="anchored" data-anchor-id="years-of-life-lost-to-disease-ylls-approach-1"><span class="header-section-number">5.3</span> Years of Life Lost to Disease (YLLs): Approach 1</h3>
<p>As noted in <a href="#sec-background" class="quarto-xref">Section&nbsp;2</a> and in <a href="#eq-yll" class="quarto-xref">Equation&nbsp;5</a>, YLLs are based on the present value of remaining life expectancy among disease-related deaths. In a discrete time Markov model, these deaths may occur in any cycle—though, like YLDs, the fully-discounted value is calculated relative to baseline (<span class="math inline">\(t=0\)</span>).</p>
<p>Define <span class="math inline">\(a_{t}\)</span> as the age of the cohort at cycle <span class="math inline">\(t\)</span>, i.e.,</p>
<p><span id="eq-aget"><span class="math display">\[
a_t = a_0 +t \cdot \Delta_t
\tag{22}\]</span></span> where <span class="math inline">\(a_0\)</span> is the age of the cohort at <span class="math inline">\(t=0\)</span>.</p>
<p>We next define <span class="math inline">\(Ex_t\)</span> as the present value of remaining life expectancy of the cohort in cycle <span class="math inline">\(t\)</span>.</p>
<p>Following the GBD discounting approach, <span class="math inline">\(Ex_{t}\)</span> is given by</p>
<p><span id="eq-pvEx"><span class="math display">\[
Ex_{t} = \frac{1}{r}\big (1 - e^{-rEx(a_{t})} \big )
\tag{23}\]</span></span></p>
<p>where <span class="math inline">\(Ex(a_t)\)</span> is the remaining life expectancy at age <span class="math inline">\(a\)</span>. <span class="math inline">\(Ex(a_t)\)</span> is drawn from either an exogenous (reference) life table, or an endogenous life table, depending on the objectives of the modeling exercise <span class="citation" data-cites="anand2019">(<a href="#ref-anand2019" role="doc-biblioref">Anand and Reddy 2019</a>)</span>.</p>
<p>To calculate YLLs, we use the Markov trace to calculate <span class="math inline">\(m_t\)</span>, the total number of new deaths from disease-related causes in each cycle. We calculate <span class="math inline">\(m_t\)</span> by taking the difference in state occupancy in the disease-related death column (<code>DS</code>) in adjacent cycles. As above, we can incorporate additional discounting and cycle adjustments into a cycle correction term <span class="math inline">\(c_t\)</span> and calculate total discounted (and cycle-corrected) YLLs as</p>
<p><span id="eq-yllt1"><span class="math display">\[
YLL_t=m_t Ex_t  \times{c_t}
\tag{24}\]</span></span></p>
<p>Total discounted YLLs are given by,</p>
<p><span id="eq-yllcum1"><span class="math display">\[
YLL=\sum_{t=1}^{\omega-1} YLL_t = \sum_{t=1}^{\omega-1}m_t Ex_{t}  \times{c_t}
\tag{25}\]</span></span></p>
</section>
<section id="years-of-life-lost-to-disease-ylls-approach-2" class="level3" data-number="5.4">
<h3 data-number="5.4" class="anchored" data-anchor-id="years-of-life-lost-to-disease-ylls-approach-2"><span class="header-section-number">5.4</span> Years of Life Lost to Disease (YLLs): Approach 2</h3>
<p>YLLs under Approach 2 can be calculated in a similar way as YLDs, since we have augmented the model with a transition tracking state that directly estimates new deaths in each cycle. Define the YLL payoff vector <span class="math inline">\(\mathbf{d}_{YLL,t}\)</span>, which has value <span class="math inline">\(Ex_{t}\)</span> for the transition tracker health state (<code>trDS</code>) and zeros elsewhere,</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><a href="images/d_yll.png" class="lightbox" data-gallery="quarto-lightbox-gallery-9"><img src="images/d_yll.png" class="img-fluid quarto-figure quarto-figure-center figure-img" style="width:40.0%"></a></p>
</figure>
</div>
<p>We can now apply similar equations as used for YLD outcomes to calculate fully discounted YLLs,</p>
<p><span id="eq-yllcum"><span class="math display">\[
YLL=\sum_{t=0}^{\omega-1} YLL(t)=\sum_{t=0}^{\omega-1}\left(\mathbf{s}'_0 \mathbf{P}_1\mathbf{P}_2\dots\mathbf{P}_t \mathbf{d}_{YLL,t}  \times c_t \right)
\tag{26}\]</span></span></p>
<p>Alternatively, using the Markov trace, we stack each <span class="math inline">\(k \times 1\)</span> payoff vector (using <span class="math inline">\(\mathbf{d}_{YLL,t}^\top\)</span> as rows) into an <span class="math inline">\(\omega \times k\)</span> payoff matrix <span class="math inline">\(\mathbf{D}\)</span>, and obtain total adjusted YLLs as</p>
<p><span id="eq-ylltrace"><span class="math display">\[
YLL = \sum_{t=0}^{\omega-1} \text{sum}(\mathbf{S} \odot \mathbf{D}) \odot \mathbf{c}
\tag{27}\]</span></span> where the <span class="math inline">\(\text{sum}()\)</span> operator sums each row across the <span class="math inline">\(k\)</span> columns that result from <span class="math inline">\(\mathbf{S} \odot \mathbf{D}\)</span>.</p>
</section>
</section>
<section id="sec-outcomes3" class="level2" data-number="6">
<h2 data-number="6" class="anchored" data-anchor-id="sec-outcomes3"><span class="header-section-number">6</span> DALY Outcomes Under Approach 3</h2>
<p>Our advanced approach draws on Markov chain with rewards methods that define reward matrices for occupancy-based (YLD) and transition-based (YLL) outcomes. These reward matrices allow us to estimate outcomes for any combination of health states and/or ages. Reward matrices have notation <span class="math inline">\(\mathbf{R}_m\)</span>, where <span class="math inline">\(m\)</span> indexes the moment of interest (e.g., expected value, variance, etc.). We focus here on expected outcomes (i.e., outcomes based on <span class="math inline">\(\mathbf{R}_1\)</span>)—though equations for higher-order moments are available in <span class="citation" data-cites="caswell2021a">Caswell and van Daalen (<a href="#ref-caswell2021a" role="doc-biblioref">2021</a>)</span>.</p>
<section id="years-of-life-lived-with-disease-yld" class="level3" data-number="6.1">
<h3 data-number="6.1" class="anchored" data-anchor-id="years-of-life-lived-with-disease-yld"><span class="header-section-number">6.1</span> Years of Life Lived With Disease (YLD)</h3>
<p>To estimate YLDs, we first define a <span class="math inline">\(\tau \times \omega\)</span> reward matrix <span class="math inline">\(\mathbf{H}\)</span>, which has dimensions <span class="math inline">\(\tau \times \omega\)</span> and is structured as shown in <a href="#fig-H-le" class="quarto-xref">Figure&nbsp;4</a>:</p>
<div id="fig-H-le" class="quarto-figure quarto-figure-center quarto-float anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-H-le-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/H-LE.png" class="lightbox" data-glightbox="description: .lightbox-desc-10" data-gallery="quarto-lightbox-gallery-10"><img src="images/H-LE.png" class="img-fluid quarto-figure quarto-figure-center figure-img" style="width:40.0%"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-H-le-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;4: YLD reward matrix <span class="math inline">\(\mathbf{H}\)</span>
</figcaption>
</figure>
</div>
<p>Cell values within this matrix can be set to one if we want to potentially “reward” that health state-age combination in our outcome measure, and zero otherwise.</p>
<p>We use this matrix to define the reward vector <span class="math inline">\(\mathbf{h}\)</span>, where <span class="math inline">\(\text{vec}\)</span> is an operator that stacks the columns of an <span class="math inline">\(m \times n\)</span> matrix into a <span class="math inline">\(mn \times 1\)</span> vector.</p>
<p><span class="math display">\[
\mathbf{h} = \text{vec } \mathbf{H}
\]</span> We also define <span class="math inline">\(\neg \mathbf{h}\)</span> as the complement of <span class="math inline">\(\mathbf{h}\)</span>, (i.e., values of 1.0 become 0, and vice versa).</p>
<p>We next define additional matrix <span class="math inline">\(\mathbf{V}\)</span>, which has the same structure as <span class="math inline">\(\mathbf{H}\)</span> but includes the (fully discounted) disability weights:</p>
<div id="fig-H-yld" class="quarto-figure quarto-figure-center quarto-float anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-H-yld-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="images/H-YLD.png" class="lightbox" data-glightbox="description: .lightbox-desc-11" data-gallery="quarto-lightbox-gallery-11"><img src="images/H-YLD.png" class="img-fluid quarto-figure quarto-figure-center figure-img" style="width:60.0%"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-H-yld-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;5: YLD reward matrix <span class="math inline">\(\mathbf{V}\)</span>
</figcaption>
</figure>
</div>
<p>where <span class="math inline">\(\texttt{dwS1}* = \texttt{dwS1} \times \Delta_t \times \frac{1}{r_{\Delta_t}}(1-e^{-r_{\Delta_t}}) \times e^{-r_{\Delta_t} t}\)</span>, etc. This equation first converts the weights into the appropriate value for the time step, applies the cycle-specific discounting adjustment factor, and then discounts the resulting value to the baseline period.</p>
<p>We similarly define an occupancy indicator vector <span class="math inline">\(\mathbf{v}\)</span> just as we did for <span class="math inline">\(\mathbf{h}\)</span>:</p>
<p><span class="math display">\[
\mathbf{v}=\operatorname{vec} \mathbf{V}
\]</span></p>
<section id="partial-occupancy" class="level4" data-number="6.1.1">
<h4 data-number="6.1.1" class="anchored" data-anchor-id="partial-occupancy"><span class="header-section-number">6.1.1</span> Partial Occupancy</h4>
<p>Because we are modeling a continuous-time disease progression progress in discrete time, it is useful to make corrections for partial occupancy in a cycle. Similar to a half-cycle correction often used in health economic applications, the Markov chain with rewards approach does so by assuming transitions occur half-way through a cycle; the application of this assumption is slightly different, however, because the correction applies in every cycle, not just the first and last. We operationalize this assumption by defining,</p>
<p><span class="math display">\[
\begin{aligned}
\widetilde{\mathbf{B}}_{1} &amp; =\mathbf{h} \mathbf{v}_{1}^{\top}+\frac{1}{2}(\neg \mathbf{h})\left(\mathbf{v}_{1}^{\top}\right)+\frac{1}{2}\left(\mathbf{v}_{1}\right)\left(\neg \mathbf{h}^{\top}\right) \\
\end{aligned}
\]</span> and</p>
<p><span class="math display">\[
\widetilde{\mathbf{C}}_{1}=\frac{1}{2} \mathbf{1}_{\alpha} \mathbf{v_1}^{\top}
\]</span> where <span class="math inline">\(\mathbf{1}_{\alpha}\)</span> is a vector of ones with length <span class="math inline">\(\alpha\)</span>.</p>
<p>We combine <span class="math inline">\(\widetilde{\mathbf{B}}_{1}\)</span> and <span class="math inline">\(\widetilde{\mathbf{C}}_{1}\)</span> to obtain the final reward matrix for expected YLD outcomes,</p>
<p><span class="math display">\[
\widetilde{\mathbf{R}}^{YLD}_{1}=\left(\begin{array}{c|c}
\widetilde{\mathbf{B}}_{1} &amp; \mathbf{0} \\
\hline \widetilde{\mathbf{C}}_{1} &amp; \mathbf{0}
\end{array}\right)
\]</span> which has same block structure and dimensions as the transition probability matrix <span class="math inline">\(\widetilde{\mathbf{P}}\)</span> (<a href="#eq-Ptilde" class="quarto-xref">Equation&nbsp;14</a>). We explain how to use this matrix to estimate expected YLDs in <a href="#sec-expected" class="quarto-xref">Section&nbsp;6.3</a> below.</p>
</section>
</section>
<section id="years-of-life-lost-to-disease-yll" class="level3" data-number="6.2">
<h3 data-number="6.2" class="anchored" data-anchor-id="years-of-life-lost-to-disease-yll"><span class="header-section-number">6.2</span> Years of Life Lost to Disease (YLL)</h3>
<p>For transition-based outcomes such as YLLs, we define the first moment of remaining life expectancy as the vector <span class="math inline">\(\widetilde{\boldsymbol{\eta}}^{\top}\)</span>. This vector has dimensions <span class="math inline">\(\tau\omega \times 1\)</span> and has the following basic structure:</p>
<p><span class="math display">\[
\widetilde{\mathbf{\eta}}=\left(\begin{array}{c}
\eta_{11} \\
\vdots \\
\eta_{\tau 1} \\
\hline \vdots \\
\hline \eta_{1 \omega} \\
\vdots \\
\eta_{\tau \omega}
\end{array}\right)
\]</span> where <span class="math inline">\(\eta_{i x}\)</span> is remaining life expectancy for an individual in health state <span class="math inline">\(i\)</span> at a given age <span class="math inline">\(x\)</span>. In this structure, remaining life expectancy for each health state is grouped within age classes. Remaining life expectancy should also enter <span class="math inline">\(\eta_{i x}\)</span> as fully discounted back to <span class="math inline">\(t=0\)</span>.</p>
<p>Our model, for example, follows a cohort of 25 year old adults until death. The GBD reference life expectancy value for a 25 year old is 64.15, and the life expectancy for the last age class (95+) is 5.92. There are also <span class="math inline">\(\tau=3\)</span> non-absorbing health states. If we followed the cohort until age 95, <span class="math inline">\(\eta_{i x}\)</span> would take the following form:</p>
<p><span class="math display">\[
\widetilde{\mathbf{\eta}}=\left(\begin{array}{c}
\eta_{H,25} =  64.15 \\
\eta_{S1,25} =  64.15 \\
\eta_{S2,25} =  64.15 \\
\hline \vdots \\
\hline \eta_{H,95} =  5.92 \\
\eta_{S1,95} = 5.92 \\
\eta_{S2,95} =  5.92 \\
\end{array}\right)
\]</span></p>
<p>We next construct the reward matrices:</p>
<p><span class="math display">\[
\begin{aligned}
\widetilde{\mathbf{B}}_{1} &amp; =\left(\mathbf{0}_{\tau \omega \times \tau \omega}\right) \\
\widetilde{\mathbf{C}}_{1} &amp; =\left(\begin{array}{c}
\widetilde{\boldsymbol{\eta}}_{1}^{\top} \\
\mathbf{0}_{1 \times \tau \omega}
\end{array}\right) .
\end{aligned}
\]</span></p>
<p>and</p>
<p><span class="math display">\[
\widetilde{\mathbf{R}}^{YLL}_{1}=\left(\begin{array}{c|c}
\mathbf{0}_{\tau \omega \times \tau \omega} &amp; \mathbf{0}_{\tau \omega \times 2} \\
\hline \widetilde{\boldsymbol{\eta}}_{1}^{\top} &amp; \mathbf{0}_{1 \times 2} \\
\mathbf{0}_{1 \times \tau \omega} &amp; \mathbf{0}_{1 \times 2}
\end{array}\right)
\]</span></p>
</section>
<section id="sec-expected" class="level3" data-number="6.3">
<h3 data-number="6.3" class="anchored" data-anchor-id="sec-expected"><span class="header-section-number">6.3</span> Expected YLD and YLL Outcomes</h3>
<p>The expected value of outcome <span class="math inline">\(Y\)</span> (where <span class="math inline">\(Y \in \{YLD, YLL\}\)</span>) is estimated by,</p>
<p><span id="eq-app3out"><span class="math display">\[
\begin{aligned}
&amp; \widetilde{\boldsymbol{\rho}}^{Y}_{1}=\widetilde{\mathbf{N}}^{\top} \mathbf{Z}\left(\widetilde{\mathbf{P}} \odot \widetilde{\mathbf{R}}^Y_{1}\right)^{\top} \mathbf{1}_{s}
\end{aligned}
\tag{28}\]</span></span> where <span class="math inline">\(\widetilde{\mathbf{N}}\)</span> is the fundamental matrix,</p>
<p><span class="math display">\[
\widetilde{\mathbf{N}}=(\mathbf{I}-\widetilde{\mathbf{U}})^{-1}
\]</span> and <span class="math inline">\(\mathbf{Z}\)</span> is</p>
<p><span class="math display">\[
\mathbf{Z}=\left(\mathbf{I}_{\tau \omega} \mid \mathbf{0}_{\tau \omega \times \alpha}\right)
\]</span></p>
<p>Total (across all ages) outcomes for each starting health state are calculated as</p>
<p><span id="eq-app3outstate"><span class="math display">\[
\boldsymbol{\rho}_{1}^{Y,\text {stage }}(\operatorname{cycle } t)=\left(\mathbf{e}_{t}^{\top} \otimes \mathbf{I}_{\tau}\right) \widetilde{\boldsymbol{\rho}}^Y_{1} \quad \tau \times 1
\tag{29}\]</span></span> where <span class="math inline">\(\otimes\)</span> is the Kronecker operator and <span class="math inline">\(\mathbf{e}_{t}\)</span> is a vector of length <span class="math inline">\(\omega\)</span> with a value of one in the first position and zero elsewhere; this facilitates calculating expected outcomes from the baseline period (i.e., <span class="math inline">\(t=0\)</span>).</p>
<p><a href="#eq-app3outstate" class="quarto-xref">Equation&nbsp;29</a> will yield expected outcomes as typically reported in health economic evaluations. Alternatively, we may wish to calculate outcomes separately under different baseline age-health state combinations (e.g., DALYs for healthy 55 year-old adults). We obtain these expected outcomes by,</p>
<p><span id="eq-app3outage"><span class="math display">\[
\boldsymbol{\rho}_{1}^{Y,\text {age }}(\text { stage } i)=\left(\mathbf{I}_{\omega} \otimes \mathbf{e}_{i}^{\top}\right) \widetilde{\boldsymbol{\rho}}^Y_{1} \quad \omega \times 1,
\tag{30}\]</span></span> where <span class="math inline">\(\mathbf{e}_{i}\)</span> is a vector of length <span class="math inline">\(\tau\)</span> with a value of one in the initial health state position of interest (e.g., <code>Healthy</code>) and zero elsewhere.</p>
</section>
</section>
<section id="sec-results" class="level2" data-number="7">
<h2 data-number="7" class="anchored" data-anchor-id="sec-results"><span class="header-section-number">7</span> Results</h2>
<section id="comparison-of-daly-outcomes-under-all-three-approaches" class="level3" data-number="7.1">
<h3 data-number="7.1" class="anchored" data-anchor-id="comparison-of-daly-outcomes-under-all-three-approaches"><span class="header-section-number">7.1</span> Comparison of DALY Outcomes Under All Three Approaches</h3>
<p><a href="#tbl-compare1" class="quarto-xref">Table&nbsp;2</a> draws on the Sick-Sicker model parameters and shows YLD, YLL and DALY outcomes estimates across the three approaches. Due to their similar structure, Approaches 1 and 2 yield identical estimates and are reported together in the table. Approach 3 draws on a slightly different partial occupancy assumption, though yields DALY estimates that are consistently within 2% of those under Approaches 1 &amp; 2. YLLs have the largest difference (up to 5%), while YLDs have the lowest (around 1%).</p>
<div class="cell">
<div id="tbl-compare1" class="cell quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-compare1-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;2: Comparison of Outcomes Under Three DALY Approaches
</figcaption>
<div aria-describedby="tbl-compare1-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<div class="cell-output-display">
<div class="tabwid"><style>.cl-f38da504{}.cl-f38abf10{font-family:'Helvetica';font-size:11pt;font-weight:bold;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-f38abf1a{font-family:'Helvetica';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-f38bf2fe{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-f38bfaec{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfaed{width:0.05in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfaee{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfaf6{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfaf7{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfaf8{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfaf9{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfb00{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f38bfb01{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 0.75pt solid rgba(102, 102, 102, 1.00);border-top: 0.75pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing="true" class="cl-f38da504"><thead><tr style="overflow-wrap:break-word;"><th class="cl-f38bfaec"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Strategy</span></p></th><th class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></th><th colspan="2" class="cl-f38bfaee"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Years Living With Disease (YLDs)</span></p></th><th class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></th><th colspan="2" class="cl-f38bfaee"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Years of Life Lost to Premature Mortality (YLLs)</span></p></th><th class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></th><th colspan="2" class="cl-f38bfaee"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Disability-Adjusted Life Years (DALYs)</span></p></th></tr><tr style="overflow-wrap:break-word;"><th class="cl-f38bfaf6"><p class="cl-f38bf2fe"><span class="cl-f38abf10"></span></p></th><th class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></th><th class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Markov Trace (1&amp;2)</span></p></th><th class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Markov Chain With Rewards (3)</span></p></th><th class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></th><th class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Markov Trace (1&amp;2)</span></p></th><th class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Markov Chain With Rewards (3)</span></p></th><th class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></th><th class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Markov Trace (1&amp;2)</span></p></th><th class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf10">Markov Chain With Rewards (3)</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td class="cl-f38bfaf8"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">Standard of Care</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfaf9"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">4.472</span></p></td><td class="cl-f38bfaf9"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">4.500</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfaf9"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.683</span></p></td><td class="cl-f38bfaf9"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.683</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfaf9"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">7.155</span></p></td><td class="cl-f38bfaf9"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">7.183</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f38bfb00"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">Strategy A: Quality of Life Improvement</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">3.786</span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">3.781</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.683</span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.683</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">6.469</span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">6.464</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f38bfb00"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">Strategy B: Reduce Disease Progression</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">3.707</span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">3.731</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.028</span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.028</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">5.734</span></p></td><td class="cl-f38bfb01"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">5.758</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f38bfaf6"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">Composite: Strategy A + Strategy B</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.866</span></p></td><td class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.862</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.028</span></p></td><td class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">2.028</span></p></td><td class="cl-f38bfaed"><p class="cl-f38bf2fe"><span class="cl-f38abf1a"></span></p></td><td class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">4.894</span></p></td><td class="cl-f38bfaf7"><p class="cl-f38bf2fe"><span class="cl-f38abf1a">4.890</span></p></td></tr></tbody></table></div>
</div>
</div>
</figure>
<a class="quarto-notebook-link" id="nblink-4" href="index-preview.html#tbl-compare1">Source: Article Notebook</a></div>
<a class="quarto-notebook-link" id="nblink-3" href="index-preview.html">Source: Article Notebook</a></div>
</section>
<section id="comparison-with-shortcut-based-daly-approaches" class="level3" data-number="7.2">
<h3 data-number="7.2" class="anchored" data-anchor-id="comparison-with-shortcut-based-daly-approaches"><span class="header-section-number">7.2</span> Comparison with “Shortcut-based” DALY Approaches</h3>
<p><a href="#tbl-cea" class="quarto-xref">Table&nbsp;3</a> reports cost, effect and incremental cost-effectiveness ratio (ICER) results for our three DALY approaches. The table also includes results under two “shortcut” DALY strategies. As above, there is a roughly 3% difference in outcome estimates, including ICERs, across our three DALY approaches.</p>
<p><a href="#tbl-cea" class="quarto-xref">Table&nbsp;3</a> also includes outcomes under alternative “shortcut”-based DALY estimation approaches. First, the method labeled <strong>death state occupancy</strong> defines cycle payoffs based on the disease weight for the diseased health states, and a payoff value of 1.0 for the disease-related death state. Inclusion of disease weights facilitates accumulation of YLDs; YLLs are calculated by accumulating time in the disease-related death state. This approach to YLLs is endogenous to the model, i.e., it does not incorporate exogenous life expectancy information from the GBD reference life table.</p>
<p>The death state occupancy method yields DALY estimates that are 32-38% higher than our three approaches, and results in an ICER that is 25% lower for Strategy A vs.&nbsp;the standard of care. The ICER for strategy AB is calculated relative to strategy B, so the only difference is additional improvement in quality life from strategy A. This improvement works exclusively through the YLD channel, as there is no differential effect on mortality. With this key information in mind, we note that the ICER for AB vs.&nbsp;B is identical for the death state occupancy method vs.&nbsp;Approaches 1 &amp; 2.</p>
<p>Next, the approach labeled <strong>QALY-like DALY</strong> defines the cycle occupancy payoff for the sick and sicker states as one minus the disability weight; as in many QALY applications, the healthy state receives a payoff value of 1.0. Because we have defined the disability weight in this example as one minus the utility weight, the <strong>QALY-like DALY</strong> approach yields estimates that are equivalent to estimating standard QALY outcomes.</p>
<p>QALY-like DALY estimates are, not surprisingly, higher than the other DALY estimates, owing to their conceptual difference with DALYs (i.e., QALYs accumulate and reward the quality and extension of life, while DALYs accumulate years lost to disease). Again, ICERs for strategy A vs.&nbsp;the standard of care are about 25% lower, while they are very similar to our DALY approaches for the AB strategy that deferentially improves quality of life.</p>
<div class="cell">
<div id="tbl-cea" class="cell quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-cea-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;3: Comparison of Cost-Effectiveness Analysis Results
</figcaption>
<div aria-describedby="tbl-cea-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<div class="cell-output-display">
<div class="tabwid"><style>.cl-f3a2a058{}.cl-f39fbc12{font-family:'Helvetica';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-f3a0e772{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-f3a0ef9c{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f3a0ef9d{width:0.05in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f3a0ef9e{width:1in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f3a0efa6{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f3a0efa7{width:1in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f3a0efa8{width:2in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-f3a0efb0{width:1in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}</style><table data-quarto-disable-processing="true" class="cl-f3a2a058"><thead><tr style="overflow-wrap:break-word;"><th class="cl-f3a0ef9c"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></th><th class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></th><th class="cl-f3a0ef9e"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Markov Trace (1&amp;2)</span></p></th><th class="cl-f3a0ef9e"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Markov Chain With Rewards (3)</span></p></th><th class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></th><th class="cl-f3a0ef9e"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Shortcut 1: Accumulate Death State Occupancy</span></p></th><th class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></th><th class="cl-f3a0ef9e"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Shortcut 2: QALY-like DALY</span></p></th></tr></thead><tbody><tr style="overflow-wrap:break-word;"><td colspan="8" class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Cost</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Standard of Care</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">158,566</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">153,685</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">158,566</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">158,566</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Strategy B: Reduce Disease Progression</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">255,608</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">247,354</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">255,608</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">255,608</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Composite: Strategy A + Strategy B</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">375,043</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">362,476</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">375,043</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">375,043</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Strategy A: Quality of Life Improvement</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">292,352</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">282,525</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">292,352</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">292,352</span></p></td></tr><tr style="overflow-wrap:break-word;"><td colspan="8" class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">DALY</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Standard of Care</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">7.16</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">7.18</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">9.62</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">21.87</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Strategy B: Reduce Disease Progression</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">5.73</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">5.76</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">7.74</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">23.7</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Composite: Strategy A + Strategy B</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">4.89</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">4.89</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">6.87</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">24.58</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Strategy A: Quality of Life Improvement</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">6.47</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">6.46</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">8.92</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">22.59</span></p></td></tr><tr style="overflow-wrap:break-word;"><td colspan="8" class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">ICER</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Standard of Care</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">ref.</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">ref.</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">ref.</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">ref.</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Strategy B: Reduce Disease Progression</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">68,314</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">65,749</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">51,524</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">53,119</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa6"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Composite: Strategy A + Strategy B</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">142,058</span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">132,583</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">137,860</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efa7"><p class="cl-f3a0e772"><span class="cl-f39fbc12">135,813</span></p></td></tr><tr style="overflow-wrap:break-word;"><td class="cl-f3a0efa8"><p class="cl-f3a0e772"><span class="cl-f39fbc12">Strategy A: Quality of Life Improvement</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efb0"><p class="cl-f3a0e772"><span class="cl-f39fbc12">D</span></p></td><td class="cl-f3a0efb0"><p class="cl-f3a0e772"><span class="cl-f39fbc12">D</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efb0"><p class="cl-f3a0e772"><span class="cl-f39fbc12">D</span></p></td><td class="cl-f3a0ef9d"><p class="cl-f3a0e772"><span class="cl-f39fbc12"></span></p></td><td class="cl-f3a0efb0"><p class="cl-f3a0e772"><span class="cl-f39fbc12">D</span></p></td></tr></tbody></table></div>
</div>
</div>
</figure>
<a class="quarto-notebook-link" id="nblink-6" href="index-preview.html#tbl-cea">Source: Article Notebook</a></div>
<a class="quarto-notebook-link" id="nblink-5" href="index-preview.html">Source: Article Notebook</a></div>
</section>
</section>
<section id="discussion" class="level2" data-number="8">
<h2 data-number="8" class="anchored" data-anchor-id="discussion"><span class="header-section-number">8</span> Discussion</h2>
<p>This study extends the methodological toolkit available to decision modelers by introducing three DALY estimation methods. Our approaches are designed to fit a full spectrum of experience and skill—thus making our methods accessible to any practitioner who aims to include DALYs in their decision model. Our results demonstrate that all three approaches yield similar values for DALY levels and incremental cost-effectiveness ratios in a didactic decision analytic progressive disease model. Finally, we also show that other shortcuts suggested for DALY outcomes do not in general yield similar results for either DALY levels or ICERs.</p>
<p>Our methods also extend to other common decision modeling frameworks. For example, Approach 2 directly estimates YLDs and YLLs in each cycle—and can therefore be adapted to efficiently execute microsimulation models in which cycle transition probabilities depend on patient attributes or disease history. Discrete event simulation models, moreover, can apply the YLD and YLL equations provided (<a href="#eq-yll" class="quarto-xref">Equation&nbsp;5</a> and <a href="#eq-yld" class="quarto-xref">Equation&nbsp;4</a>) to simulated time-to-death and duration of disease values.</p>
<p>A subset of our results yielded similar or even exact values when comparing DALY shortcuts to our DALY approaches, so it is useful to walk through the circumstances when various approaches will be similar and differ. In general, DALY shortcut methods will be more accurate when YLDs dominate the DALY value. The reason is that our methods, as well as standard (“QALY-like”) methods, apply identical payoff weights to occupancy in diseased states. The methods differ substantially, however, in how they “reward” deaths from disease. Our methods mirror the GBD approach of penalizing a disease-related death using an exogenous remaining life expectancy value. Shortcut-based methods, by comparison, accumulate time in the disease-related death state—thus, the payoffs are determined endogenously within the model. Moreover, because a payoff value is applied to an absorbing state, results under the shortcut-based DALY method will be highly sensitive to the time horizon in a model. That is, “YLLs” will continue to accumulate even after all cohort members have died. This will not impact ICER calculations that make comparisons <em>across</em> strategies, but will yield inaccurate DALY levels in a modeled population. Reflecting the above observations, our ICER results comparing strategy AB to B—where the only difference is in the improved quality-of-life from strategy A, which will affect YLDs but not YLLs—are identical using Approaches 1&amp;2 and using the shortcut method based on accumulating time in the death state.</p>
<p>Another important consideration is the role of discounting. Our approaches apply continuous-time discounting approach to maintain consistency with the GBD assumption that remaining life expectancy accrues as a continuous “flow” of health. This manifests in our approaches through the use of a cycle-specific discount factor (<span class="math inline">\(\frac{1}{r_{\Delta_t}}(1-e^{-r_{\Delta_t}})\)</span>) and a continuous-time formula <span class="math inline">\(e^{-rt}\)</span> to discount values to baseline. If practitioners do not wish to discount, the discount rate value can simply be set to zero.<a href="#fn15" class="footnote-ref" id="fnref15" role="doc-noteref"><sup>15</sup></a> Alternatively, practitioners may also elect to use the standard discrete time discounting formula (<span class="math inline">\(\frac{1}{(1+r^*)^t}\)</span>), but can first convert the discount rate as <span class="math inline">\(r^*=e^{r}-1\)</span>.</p>
<p>Finally, it is important to note that the methods outlined here are not purely restricted to DALY outcomes. Indeed, all three approaches facilitate the estimation of other common outcomes such as QALYs, life-years, etc. The adaption of the healthy longevity approach developed in <span class="citation" data-cites="caswell2021a">Caswell and van Daalen (<a href="#ref-caswell2021a" role="doc-biblioref">2021</a>)</span> to common decision modeling environments, in particular, opens up new outcomes (e.g., variance of QALYs) and flexible new methods for decision modelers.</p>
</section>
<section id="references" class="level2 unnumbered">
<h2 class="unnumbered anchored" data-anchor-id="references">References</h2>
<div id="refs" class="references csl-bib-body hanging-indent" data-entry-spacing="0" role="list">
<div id="ref-alarid2023introductory" class="csl-entry" role="listitem">
Alarid-Escudero, Fernando, Eline Krijkamp, Eva A Enns, Alan Yang, MG Myriam Hunink, Petros Pechlivanoglou, and Hawre Jalal. 2023. <span>“An Introductory Tutorial on Cohort State-Transition Models in r Using a Cost-Effectiveness Analysis Example.”</span> <em>Medical Decision Making</em> 43 (1): 3–20.
</div>
<div id="ref-anand2019" class="csl-entry" role="listitem">
Anand, Sudhir, and Sanjay G. Reddy. 2019. <span>“The Construction of the DALY: Implications and Anomalies.”</span> <em>SSRN Electronic Journal</em>. <a href="https://doi.org/10.2139/ssrn.3451311">https://doi.org/10.2139/ssrn.3451311</a>.
</div>
<div id="ref-bertram2021" class="csl-entry" role="listitem">
Bertram, Melanie Y., Jeremy A. Lauer, Karin Stenberg, and Tessa Tan Torres Edejer. 2021. <span>“Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE.”</span> <em>International Journal of Health Policy and Management</em>, January. <a href="https://doi.org/10.34172/ijhpm.2020.244">https://doi.org/10.34172/ijhpm.2020.244</a>.
</div>
<div id="ref-caswell2021a" class="csl-entry" role="listitem">
Caswell, Hal, and Silke van Daalen. 2021. <span>“Healthy Longevity from Incidence-Based Models: More Kinds of Health Than Stars in the Sky.”</span> <em>Demographic Research</em> 45 (July): 397–452. <a href="https://doi.org/10.4054/demres.2021.45.13">https://doi.org/10.4054/demres.2021.45.13</a>.
</div>
<div id="ref-caswell2018" class="csl-entry" role="listitem">
Caswell, Hal, and Virginia Zarulli. 2018. <span>“Matrix Methods in Health Demography: A New Approach to the Stochastic Analysis of Healthy Longevity and DALYs.”</span> <em>Population Health Metrics</em> 16 (1). <a href="https://doi.org/10.1186/s12963-018-0165-5">https://doi.org/10.1186/s12963-018-0165-5</a>.
</div>
<div id="ref-Feng2020" class="csl-entry" role="listitem">
Feng, Xue, David D. Kim, Joshua T. Cohen, Peter J. Neumann, and Daniel A. Ollendorf. 2020. <span>“Using QALYs Versus DALYs to Measure Cost-Effectiveness: How Much Does It Matter?”</span> <em>International Journal of Technology Assessment in Health Care</em> 36 (2): 96–103. <a href="https://doi.org/10.1017/s0266462320000124">https://doi.org/10.1017/s0266462320000124</a>.
</div>
<div id="ref-rushby2001" class="csl-entry" role="listitem">
Fox-Rushby, Ja, and K Hanson. 2001. <span>“Calculating and Presenting Disability Adjusted Life Years (DALYs) in Cost-Effectiveness Analysis.”</span> <em>Health Policy and Planning</em> 16 (3): 326–31. <a href="https://doi.org/10.1093/heapol/16.3.326">https://doi.org/10.1093/heapol/16.3.326</a>.
</div>
<div id="ref-globalburdenofdiseasecollaborativenetwork2021" class="csl-entry" role="listitem">
Global Burden of Disease Collaborative Network. 2021. <span>“Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table.”</span> Institute for Health Metrics; Evaluation (IHME). <a href="https://doi.org/10.6069/1D4Y-YQ37">https://doi.org/10.6069/1D4Y-YQ37</a>.
</div>
<div id="ref-graves2021" class="csl-entry" role="listitem">
Graves, John, Shawn Garbett, Zilu Zhou, Jonathan S. Schildcrout, and Josh Peterson. 2021. <span>“Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation.”</span> <em>Medical Decision Making</em> 41 (4): 453–64. <a href="https://doi.org/10.1177/0272989x21995805">https://doi.org/10.1177/0272989x21995805</a>.
</div>
<div id="ref-henderson1981" class="csl-entry" role="listitem">
Henderson, Harold V., and S. R. Searle. 1981. <span>“The Vec-Permutation Matrix, the Vec Operator and Kronecker Products: A Review.”</span> <em>Linear and Multilinear Algebra</em> 9 (4): 271–88. <a href="https://doi.org/10.1080/03081088108817379">https://doi.org/10.1080/03081088108817379</a>.
</div>
<div id="ref-iosifescu1980" class="csl-entry" role="listitem">
Iosifescu, M. 1980. <span>“Finite Markov Processes and Their Applications. Wiley.”</span> <em>New York</em>.
</div>
<div id="ref-larson2013calculating" class="csl-entry" role="listitem">
Larson, Bruce A. 2013. <span>“Calculating Disability-Adjusted-Life-Years Lost (DALYs) in Discrete-Time.”</span> <em>Cost Effectiveness and Resource Allocation</em> 11 (1): 1–6.
</div>
<div id="ref-murray2020" class="csl-entry" role="listitem">
Murray, Christopher J L, Aleksandr Y Aravkin, Peng Zheng, Cristiana Abbafati, Kaja M Abbas, Mohsen Abbasi-Kangevari, Foad Abd-Allah, et al. 2020. <span>“Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990<span></span>2019: A Systematic Analysis for the Global Burden of Disease Study 2019.”</span> <em>The Lancet</em> 396 (10258): 1223–49. <a href="https://doi.org/10.1016/s0140-6736(20)30752-2">https://doi.org/10.1016/s0140-6736(20)30752-2</a>.
</div>
<div id="ref-Murray1997" class="csl-entry" role="listitem">
Murray, Christopher JL, and Alan D Lopez. 1997. <span>“Mortality by Cause for Eight Regions of the World: Global Burden of Disease Study.”</span> <em>The Lancet</em> 349 (9061): 1269–76. <a href="https://doi.org/10.1016/s0140-6736(96)07493-4">https://doi.org/10.1016/s0140-6736(96)07493-4</a>.
</div>
<div id="ref-sassi2006calculating" class="csl-entry" role="listitem">
Sassi, Franco. 2006. <span>“Calculating QALYs, Comparing QALY and DALY Calculations.”</span> <em>Health Policy and Planning</em> 21 (5): 402–8.
</div>
<div id="ref-who2020methods" class="csl-entry" role="listitem">
WHO, Geneva. 2013. <span>“WHO Methods and Data Sources for Global Burden of Disease Estimates 2000–2019.”</span> <em>Geneva: Department of Health Statistics and Information Systems</em>. <a href="https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf">https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf</a>.
</div>
<div id="ref-Wilkinson2016" class="csl-entry" role="listitem">
Wilkinson, Thomas, Mark J. Sculpher, Karl Claxton, Paul Revill, Andrew Briggs, John A. Cairns, Yot Teerawattananon, et al. 2016. <span>“The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.”</span> <em>Value in Health</em> 19 (8): 921–28. <a href="https://doi.org/10.1016/j.jval.2016.04.015">https://doi.org/10.1016/j.jval.2016.04.015</a>.
</div>
</div>
<div class="hidden" aria-hidden="true">
<span class="glightbox-desc lightbox-desc-1">Figure&nbsp;1: State transition diagram for progressive disease model</span>
<span class="glightbox-desc lightbox-desc-2">Figure&nbsp;2: State transition diagram for progressive disease model with separate cause-specific death state</span>
<span class="glightbox-desc lightbox-desc-3">Transition Intensity Matrix for Approach 1</span>
<span class="glightbox-desc lightbox-desc-4">Transition Probability Matrix for Approach 1</span>
<span class="glightbox-desc lightbox-desc-5">Figure&nbsp;3: State Transition Diagram with Transition State (Red)</span>
<span class="glightbox-desc lightbox-desc-6">Transition intensity matrix with transition state added</span>
<span class="glightbox-desc lightbox-desc-7">Transition Probability Matrix for Approach 2</span>
<span class="glightbox-desc lightbox-desc-10">Figure&nbsp;4: YLD reward matrix <span class="math inline">\(\mathbf{H}\)</span></span>
<span class="glightbox-desc lightbox-desc-11">Figure&nbsp;5: YLD reward matrix <span class="math inline">\(\mathbf{V}\)</span></span>
</div>
</section>


<div id="quarto-appendix" class="default"><section id="footnotes" class="footnotes footnotes-end-of-document" role="doc-endnotes"><h2 class="anchored quarto-appendix-heading">Footnotes</h2>

<ol>
<li id="fn1"><p>The adoption of DALYs over other common health outcomes in health economics (e.g., quality-adjusted life years, or QALYs) stems from several practical and theoretical considerations. See <span class="citation" data-cites="Feng2020">Feng et al. (<a href="#ref-Feng2020" role="doc-biblioref">2020</a>)</span> and <span class="citation" data-cites="Wilkinson2016">Wilkinson et al. (<a href="#ref-Wilkinson2016" role="doc-biblioref">2016</a>)</span> for further discussion.<a href="#fnref1" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn2"><p>In contrast, QALYs are calculated based on utility weights derived from general and patient surveys. See <span class="citation" data-cites="Feng2020">Feng et al. (<a href="#ref-Feng2020" role="doc-biblioref">2020</a>)</span> and <span class="citation" data-cites="Wilkinson2016">Wilkinson et al. (<a href="#ref-Wilkinson2016" role="doc-biblioref">2016</a>)</span> for further discussion.<a href="#fnref2" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn3"><p>Practitioners who do not wish to discount DALY outcomes can simply set the annual discount rate <span class="math inline">\(r\)</span> to zero.<a href="#fnref3" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn4"><p>In this example, disease-specific death rates are governed by a hazard ratio applied to the background mortality rate. Because we are operating on the rate scale, we can separate out disease-related deaths from other-cause mortality by simply taking a difference in the rates. Other applications for prevalent conditions with high death rates, however, may require us to construct a cause-deleted life table to obtain background mortality rates that net out deaths from the modeled disease.<a href="#fnref4" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn5"><p>In Markov theory, <span class="math inline">\(\mathbf{P}\)</span> is called the “discrete skeleton” of the continuous model <span class="citation" data-cites="iosifescu1980">(<a href="#ref-iosifescu1980" role="doc-biblioref">Iosifescu 1980</a>)</span>. The conversion formula used to calculate <span class="math inline">\(mathbf{P}\)</span> is the matrix analogue to the standard rate-to-probability formula commonly taught in health economics textbooks, i.e., <span class="math inline">\(p = 1 - e^{r\Delta t}\)</span>, where <span class="math inline">\(r\)</span> is the rate and <span class="math inline">\(\Delta t\)</span> is the time step (i.e., “cycle length”).<a href="#fnref5" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn6"><p>For example, in the continuous time rate matrix <span class="math inline">\(\mathbf{Q}_t\)</span> above, there is a zero-valued rate defined for progressions from Healthy (H) to Disease-related death (DS), since individuals must first become ill before they can die from disease-related causes. However, after embedding, the matrix <span class="math inline">\(\mathbf{P}\)</span> has a non-zero cycle transition probability from Healthy (H) to Disease-related death (DS) (i.e., <span class="math inline">\(\texttt{p\_HDS}\)</span>). This value captures the probability of a compound or “jumpover” transition from Healthy and through the Sick and/or Sicker state to death from disease-related causes within the same discrete time cycle; see <span class="citation" data-cites="graves2021">Graves et al. (<a href="#ref-graves2021" role="doc-biblioref">2021</a>)</span> for further discussion, and <span class="citation" data-cites="iosifescu1980">Iosifescu (<a href="#ref-iosifescu1980" role="doc-biblioref">1980</a>)</span> for additional theory.[^comparison]<a href="#fnref6" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn7"><p>Tracking states also allow for accurate bookkeeping for other outcomes such as costs. For example, if developing the disease incurs a one-time diagnosis or treatment cost, the compound transitions implied by the embedded transition probability matrix indicate that some individuals will transiently enter (and then exit) the Sick state in a single cycle. When calculating costs, practitioners may want to include a tracking state for the Sick state to be sure to capture these one-time costs, which would be masked if cost payoffs are simply multiplied by state occupancy at the end of each cycle (e.g., costs for individuals with a sojourn through the Sick state in a single cycle would not be accounted for).<a href="#fnref7" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn8"><p>More generally, accumulator and transition states can be defined for any number of transition types, as they are useful for capturing one-time costs in the model, or for for calculating other decision-relevant outcomes such as the total number of people who developed the disease or died from the disease as secondary outcomes.<a href="#fnref8" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn9"><p>For an example of how to do this using Global Burden of Disease cause of death and life table data, see the <a href="https://graveja0.github.io/vchem-website/blog/posts/modeling-dalys/modeling-dalys.html">example here</a><a href="#fnref9" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn10"><p>To build on the example of compound “jump-over” transitions above, suppose an individual starts off healthy in a cycle, then rapidly transitions through the Sick and Sicker state and dies due to disease-related causes within the same cycle. If there is some treatment cost associated with being in the Sicker state, a traditional approach that applies cost payoffs to state occupancy at the (beginning) end of the cycle would miss treatment costs for this individual because they <em>transition</em> through the Sicker state, but never occupy it at the beginning or end of a cycle. Adding a non-Markovian transition state to the model facilitates more accurate bookkeeping because the transition state would pick up on this transition through the Sicker state.<a href="#fnref10" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn11"><p>The method also easily accommodates other common outcomes such as QALYs and costs.<a href="#fnref11" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn12"><p>See <span class="citation" data-cites="henderson1981">Henderson and Searle (<a href="#ref-henderson1981" role="doc-biblioref">1981</a>)</span> and Appendix B in <span class="citation" data-cites="caswell2021a">Caswell and van Daalen (<a href="#ref-caswell2021a" role="doc-biblioref">2021</a>)</span> for further information. A function to construct a vec-permutation matrix is provided within our replication code.<a href="#fnref12" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn13"><p>For a time-homogeneous model, <a href="#eq-trace" class="quarto-xref">Equation&nbsp;15</a> simplifies to <span class="math inline">\(\mathbf{s}^\top_t=\mathbf{s}^\top_0 \mathbf{P}^t\)</span>.<a href="#fnref13" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn14"><p>Common discounting formulas, such as the discrete time discount factor <span class="math inline">\(\frac{1}{(1+r)^t}\)</span>, as well as the continuous time discount factor <span class="math inline">\(e^{-rt}\)</span>, are designed for a series of discrete “payoffs” at specific time points. By comparison, the continuous time discounting used in the GBD DALY equations (<a href="#eq-yld" class="quarto-xref">Equation&nbsp;4</a> and <a href="#eq-yll" class="quarto-xref">Equation&nbsp;5</a>) is based on an assumption that payoffs accrue in a continuous stream. The discount adjustment factor shown here (<span class="math inline">\(\frac{1}{r}(1-e^{-rt})\)</span>)—and introduced in <span class="citation" data-cites="larson2013calculating">Larson (<a href="#ref-larson2013calculating" role="doc-biblioref">2013</a>)</span>)—essentially “smooths out” the discrete YLD weight applied in each cycle to reflect this continuous flow. We have verified that application of this factor in our approach exactly replicate the example results using the GBD equations in <span class="citation" data-cites="rushby2001">Fox-Rushby and Hanson (<a href="#ref-rushby2001" role="doc-biblioref">2001</a>)</span>; see the Supplementary Appendix for these examples and code.<a href="#fnref14" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn15"><p>Our R code cannot accomodate a discout rate of precisely zero; instead, a value such as 1e-6 can be used.<a href="#fnref15" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
</ol>
</section><section class="quarto-appendix-contents" id="quarto-citation"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@online{graves2024,
  author = {Graves, John and Leech, Ashley and Zhu, Jinyi and Martin,
    Marie and Garbett, Shawn},
  title = {Modeling {Disability-Adjusted} {Life} {Years} for {Policy}
    and {Decision} {Analysis}},
  date = {2024-03-21},
  langid = {en},
  abstract = {This study outlines methods for direct incorporation of
    multidimensional health outcomes in common decision modeling
    frameworks, with a particular focus on disability-adjusted life
    years (DALYs) and its constituent parts-\/-\/-years of life lived
    with disability (YLDs) and years of life lost to premature mortality
    (YLLs). Recognizing the wide spectrum of experience and programming
    comfort level among practitioners, we offer three approaches
    (beginner, intermediate and advanced). Our beginner approach draws
    on the Markov trace, while the intermediate approach facilitates
    more efficient estimation for computationally-intensive exercises
    (e.g., microsimulation, probabilistic sensitivity analyses) by
    incorporating non-Markovian tracking elements into transition
    probability matrices. Finally, our advanced approach adapts methods
    from mathematical demography. This approach allows for direct
    calculation of expected values without the need for a Markov trace,
    and facilitates additional insights because it can also solve for
    higher-order moments in the health outcome distribution (e.g.,
    variance, skewness). Drawing on an existing disease progression
    discrete time Markov cohort model, we demonstrate exact or near-
    numeric equivalence of DALY estimates and cost-effectiveness
    analysis results across our three methods, and show that other
    commonly used “shortcuts” for estimating DALYs will not, in general,
    yield accurate estimates of DALY levels nor ICERs in a modeled
    population.}
}
</code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-graves2024" class="csl-entry quarto-appendix-citeas" role="listitem">
Graves, John, Ashley Leech, Jinyi Zhu, Marie Martin, and Shawn Garbett.
2024. <span>“Modeling Disability-Adjusted Life Years for Policy and
Decision Analysis.”</span> Citation Title. March 21, 2024.
</div></div></section></div></main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      // TODO in 1.5, we should make sure this works without a callout special case
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->
<script>var lightboxQuarto = GLightbox({"closeEffect":"zoom","selector":".lightbox","openEffect":"zoom","descPosition":"bottom","loop":false});
window.onload = () => {
  lightboxQuarto.on('slide_before_load', (data) => {
    const { slideIndex, slideNode, slideConfig, player, trigger } = data;
    const href = trigger.getAttribute('href');
    if (href !== null) {
      const imgEl = window.document.querySelector(`a[href="${href}"] img`);
      if (imgEl !== null) {
        const srcAttr = imgEl.getAttribute("src");
        if (srcAttr && srcAttr.startsWith("data:")) {
          slideConfig.href = srcAttr;
        }
      }
    } 
  });

  lightboxQuarto.on('slide_after_load', (data) => {
    const { slideIndex, slideNode, slideConfig, player, trigger } = data;
    if (window.Quarto?.typesetMath) {
      window.Quarto.typesetMath(slideNode);
    }
  });

};
          </script>




</body></html>